image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
a5eedfbfa8eb069fd2e0fcdb947decbd313f6affe3b3b04fcd8c402e2459b884.png | complex | <table><tr><td rowspan="2">Urea Concentration (M)</td><td colspan="7">Mn Content (%)</td></tr><tr><td>5</td><td>10</td><td>20</td><td>40</td><td>60</td><td>80</td><td>100</td></tr><tr><td>0.5</td><td>4.59</td><td>1.66</td><td>3.386</td><td>0.896</td><td>3.808</td><td>3.585</td><td>2.488</td></tr><tr><td>1.0</td><td>3.089</td><td>0.685</td><td>2.964</td><td>0.136</td><td>2.739</td><td>1.973</td><td>2.385</td></tr><tr><td>2.0</td><td>2.732</td><td>2.439</td><td>2.135</td><td>0.085</td><td>2.256</td><td>2.244</td><td>2.403</td></tr></table> |
ffbaff2cfee3c3bc840fdae42cf3396502ec0136d0c1f835a83051a6603f277b.png | complex | <table><tr><td>Clinical Features</td><td colspan="2">MBD5-specific mutation<sup>20,22–24</sup></td><td colspan="2">2q23.1 Deletion<sup>20,22–24</sup></td><td>Case in this study</td></tr><tr><td> </td><td>Number</td><td>Percentage</td><td>Number</td><td>Percentage</td><td>+, present; - absent</td></tr><tr><td>Neurological</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Development delay</td><td>20/21</td><td>95%</td><td>53/55</td><td>96%</td><td>+</td></tr><tr><td> Language impairment</td><td>12/21</td><td>57%</td><td>38/55</td><td>69%</td><td>+</td></tr><tr><td> Seizure</td><td>11/21</td><td>52%</td><td>32/55</td><td>58%</td><td>+</td></tr><tr><td> Infantile spasms</td><td>0/21</td><td>0</td><td>0/55</td><td>0</td><td>+</td></tr><tr><td> Infantile hypotonia</td><td>4/21</td><td>19%</td><td>23/55</td><td>41%</td><td>+</td></tr><tr><td>Growth/Endocrine</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Short stature</td><td>5/21</td><td>24%</td><td>25/55</td><td>45%</td><td>-</td></tr><tr><td> Local hirsutism</td><td>0/21</td><td>0</td><td>4/55</td><td>7%</td><td>-</td></tr><tr><td>Craniofacial abnormalities</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Coarse face</td><td>0/21</td><td>0</td><td>3/55</td><td>5%</td><td>+</td></tr><tr><td> Broad forehead</td><td>3/21</td><td>14%</td><td>4/55</td><td>7%</td><td>+</td></tr><tr><td> Microcephaly</td><td>1/21</td><td>5%</td><td>26/55</td><td>47%</td><td>+(<2SD)</td></tr><tr><td> Synophrys</td><td>2/21</td><td>9%</td><td>10/55</td><td>18%</td><td>+mild</td></tr><tr><td> Nasal abnormalities</td><td>7/21</td><td>33%</td><td>35/55</td><td>64%</td><td>+</td></tr><tr><td> Open mouth</td><td>3/21</td><td>14%</td><td>23/55</td><td>42%</td><td>+</td></tr><tr><td> Downturned corners of the mouth</td><td>3/21</td><td>14%</td><td>17/55</td><td>31%</td><td>+</td></tr><tr><td> Macroglossia or protruding tongue</td><td>2/21</td><td>9%</td><td>6/55</td><td>11%</td><td>-</td></tr><tr><td> Dental abnormalities</td><td>4/21</td><td>19%</td><td>13/55</td><td>24%</td><td> </td></tr><tr><td>Skeletal abnormalities</td><td> </td><td> </td><td> </td><td> </td><td>+</td></tr><tr><td> Small hands and feet</td><td>1/21</td><td>5%</td><td>23/55</td><td>42%</td><td>+</td></tr><tr><td> Clinodactyly, 5th finger</td><td>2/21</td><td>9%</td><td>22/55</td><td>40%</td><td>+</td></tr><tr><td> Brachydactyly</td><td>0/21</td><td>0</td><td>13/55</td><td>24%</td><td>+</td></tr><tr><td> Short fifth digit of hands/feet</td><td>1/21</td><td>5%</td><td>14/55</td><td>25%</td><td>+</td></tr><tr><td> Absent hallux</td><td>0/21</td><td>0</td><td>0/55</td><td>0</td><td>+</td></tr><tr><td>Behaviors</td><td> </td><td> </td><td> </td><td> </td><td>-</td></tr><tr><td> Autistic feature</td><td>13/21</td><td>62%</td><td>44/55</td><td>80%</td><td>+</td></tr><tr><td> Sleep disturbance</td><td>5/21</td><td>24%</td><td>17/55</td><td>31%</td><td>ND</td></tr><tr><td> Self-injurious behavior</td><td>2/21</td><td>9%</td><td>17/55</td><td>31%</td><td>+</td></tr><tr><td>Other</td><td> </td><td> </td><td> </td><td> </td><td>-</td></tr><tr><td> Cardiovascular abnormalities</td><td>1/21</td><td>5%</td><td>4/55</td><td>7%</td><td>-</td></tr><tr><td> Urogenital abnormalities</td><td>1/21</td><td>45%</td><td>1/55</td><td>2%</td><td>-</td></tr></table> |
679f06a83ff804a214dbbba312728a1730063003fc58b59cb2f4e7cbb2d4a71d.png | complex | <table><tr><td></td><td colspan="3">Dementia can be cured through divine healing, such as through prayer</td><td colspan="3">People with dementia should be placed in ‘homes’</td></tr><tr><td></td><td><i>B</i></td><td>β</td><td><i>t</i></td><td><i>B</i></td><td>β</td><td><i>t</i></td></tr><tr><td>Age</td><td>0.013</td><td>0.013</td><td>0.333</td><td>0.134</td><td>0.141</td><td>3.495***</td></tr><tr><td>Gender</td><td>−0.029</td><td>−0.012</td><td>−0.377</td><td>−0.024</td><td>−0.011</td><td>−0.328</td></tr><tr><td>Ethnic</td><td>0.069</td><td>0.051</td><td>1.546</td><td>0.022</td><td>0.018</td><td>0.520</td></tr><tr><td>Religion</td><td>−0.057</td><td>−0.286</td><td>−8.938***</td><td>−0.002</td><td>−0.012</td><td>−0.377</td></tr><tr><td>Education</td><td>0.034</td><td>0.063</td><td>1.610</td><td>−0.029</td><td>−0.058</td><td>−1.427</td></tr><tr><td></td><td colspan="2">Multiple R=0.301</td><td></td><td colspan="2">Multiple R=0.186</td><td></td></tr><tr><td></td><td colspan="2">R<sup>2</sup>=0.091</td><td></td><td colspan="2">R<sup>2</sup>=0.034</td><td></td></tr><tr><td></td><td colspan="3">Adjusted R square=0.086</td><td colspan="3">Adjusted R square=0.029</td></tr><tr><td></td><td colspan="2">F=18.810***</td><td></td><td colspan="2">F=6.730***</td><td></td></tr></table> |
09b3ace1d198fa113b5a51f8ad5b06ae2576c63fc9c692ab09fb2bcbef7032e9.png | complex | <table><tr><td></td><td colspan="5">Domains of quality of life <sup>d</sup></td></tr><tr><td>Characteristics</td><td>Physical Mean (SD)</td><td>Psychological Mean (SD)</td><td>Social Mean (SD)</td><td>Environmental Mean (SD)</td><td>Global Mean (SD)</td></tr><tr><td>Diagnosis</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Stroke</td><td>41.26 (15.49)***</td><td>40.47 (15.31)***</td><td>51.04 (17.37)***</td><td>46.04 (17.41)***</td><td>45.2 (23.14)***</td></tr><tr><td> Non-stroke</td><td>67.45 (15.69)</td><td>64.76 (17.19)</td><td>71.25 (15.03)</td><td>61.71 (15.26)</td><td>65.46 (18.58)</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Male</td><td>61.99 (19.38)***</td><td>61.09 (19.97)***</td><td>68.15 (17.98)***</td><td>60.35 (17.86)***</td><td>62.36 (21.51)***</td></tr><tr><td> Female</td><td>55.25 (19.95)</td><td>51.9 (19.28)</td><td>60.59 (18.25)</td><td>52.33 (16.41)</td><td>54.78 (22.60)</td></tr><tr><td>Education <sup>a</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>54.84 (19.31)***</td><td>53.24 (18.50)***</td><td>61.87 (17.66)***</td><td>52.59 (16.18)***</td><td>55.45 (21.83)***</td></tr><tr><td> High</td><td>68.93 (17.83)</td><td>65.59 (21.56)</td><td>71.42 (18.85)</td><td>66.63 (17.25)</td><td>67.20 (21.49)</td></tr><tr><td>Income <sup>b</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>54.46 (18.45)***</td><td>51.15 (19.01)***</td><td>61.41 (17.61)***</td><td>51.20 (16.43)***</td><td>54.78 (22.02)***</td></tr><tr><td> High</td><td>62.15 (20.42)</td><td>61.05 (19.98)</td><td>66.98 (18.82)</td><td>60.69 (17.43)</td><td>61.83 (22.14)</td></tr><tr><td>Psychological stress <sup>c</sup></td><td>-0.339 ***</td><td>-0.247 ***</td><td>-0.231 ***</td><td>-0.245 ***</td><td>-0.284 ***</td></tr></table> |
f3964f6a2426fcfc2472ed4a0d3ba993082709aa88fa388f3f8fbed4c5b126ba.png | simple | <table><tr><td></td><td>No cancer</td><td>Cancer</td><td>Total</td></tr><tr><td>Mammogram (+)</td><td>20</td><td>10</td><td>32</td></tr><tr><td>Mammogram (−)</td><td>21</td><td>1</td><td>21</td></tr><tr><td>Total</td><td>41</td><td>11</td><td>52</td></tr><tr><td>Measure</td><td>Sn = 91 %</td><td>Sp = 51 %</td><td></td></tr></table> |
068d59979b22ae62902570af3c8c6b3edac99fc0d20bdd3dd8c558651b8482ea.png | complex | <table><tr><td colspan="8">HtMM</td></tr><tr><td colspan="8">Normalized jerk</td></tr><tr><td colspan="4">Dominant</td><td colspan="4">Nondominant</td></tr><tr><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td></tr><tr><td><i>R</i> = 0.75<i>p</i> < 10<sup>–6</sup></td><td><i>R</i> = 0.84<i>p</i> < 10<sup>–5</sup></td><td><i>R</i> = 0.79<i>p</i> < 10<sup>–5</sup></td><td><i>R</i> = 0.80<i>p</i> < 10<sup>–17</sup></td><td><i>R</i> = 0.75<i>p</i> < 10<sup>–6</sup></td><td><i>R</i> = 0.65<i>p</i> = 0.002</td><td><i>R</i> = 0.67<i>p</i> < 10<sup>–3</sup></td><td><i>R</i> = 0.71<i>p</i> < 10<sup>–12</sup></td></tr><tr><td colspan="8">Acceleration coefficient of periodicity</td></tr><tr><td colspan="4">Dominant</td><td colspan="4">Nondominant</td></tr><tr><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td><td>Young adults</td><td>Middle aged</td><td>Senior</td><td>All</td></tr><tr><td><i>R</i> = −0.43<i>p</i> = 0.010</td><td><i>R</i> = −0.63<i>p</i> = 0.004</td><td><i>R</i> = −0.66<i>p</i> < 10<sup>–3</sup></td><td><i>R</i> = −0.61<i>p</i> < 10<sup>–8</sup></td><td><i>R</i> = −0.61<i>p</i> < 10<sup>–3</sup></td><td><i>R</i> = −0.36<i>p</i> = 0.135</td><td><i>R</i> = −0.47<i>p</i> = 0.022</td><td><i>R</i> = −0.51<i>p</i> < 10<sup>–5</sup></td></tr></table> |
afc89447d928941bfeee5482cecbf3f03e949cdb4abc00b7b9660b8f5580223a.png | complex | <table><tr><td>Group</td><td>Ace genotype</td><td>Presence</td><td>Absence</td><td>Total</td><td>X<sup>2</sup></td><td>p</td><td>X<sup>2</sup></td><td>p</td><td>OR (CI 5-95%)</td></tr><tr><td rowspan="3">Without taking <i>CFTR</i> mutation into account</td><td>I/I</td><td>8</td><td>64</td><td>72</td><td rowspan="3">8.654</td><td rowspan="3">0.013</td><td>0.468</td><td>0.498</td><td>0.699 (0.319 – 1.534)</td></tr><tr><td>I/D</td><td>9</td><td>74</td><td>82</td><td>0.814</td><td>0.182</td><td>0.651 (0.304 – 1.394)</td></tr><tr><td>D/D</td><td>8</td><td>16</td><td>24</td><td>8,653</td><td>0.003</td><td>4.509 (1.513 – 10.89)</td></tr><tr><td rowspan="3">No identified <i>CFTR</i> mutation</td><td>I/I</td><td>3</td><td>18</td><td>21</td><td rowspan="3">0.530</td><td rowspan="3">0.767</td><td>0.003</td><td>1.29</td><td>1.056 (0.188 - 5.925)</td></tr><tr><td>I/D</td><td>2</td><td>16</td><td>18</td><td>0.204</td><td>1.00</td><td>0.656 (0.107 - 4.041)</td></tr><tr><td>D/D</td><td>1</td><td>3</td><td>4</td><td>0.438</td><td>0.93</td><td>2.267 (0.196 - 26.27)</td></tr><tr><td rowspan="3">One <i>CFTR</i> mutation identified class I, II or III</td><td>I/I</td><td>2</td><td>20</td><td>22</td><td rowspan="3">5.539</td><td rowspan="3">0.063</td><td>1.248</td><td>0.466</td><td>0.383 (0.069 - 2.117)</td></tr><tr><td>I/D</td><td>2</td><td>18</td><td>20</td><td>0.787</td><td>0.629</td><td>0.463 (0.084 - 2.562)</td></tr><tr><td>D/D</td><td>4</td><td>5</td><td>9</td><td>6.834</td><td>0.027</td><td>7.6 (1.43 - 40.38)</td></tr><tr><td rowspan="3">Two <i>CFTR</i> mutation identified class I, II or III</td><td>I/I</td><td>3</td><td>26</td><td>29</td><td rowspan="3">0.511</td><td rowspan="3">0.774</td><td>0.084</td><td>1.07</td><td>0.8077 (0.193 - 3.387)</td></tr><tr><td>I/D</td><td>5</td><td>40</td><td>45</td><td>0.039</td><td>1.10</td><td>0.875 (0.234 - 3.275)</td></tr><tr><td>D/D</td><td>2</td><td>9</td><td>11</td><td>0.495</td><td>0.764</td><td>1.833 (0.335 - 10.02)</td></tr></table> |
7ba2d83e38f75961abc498dd6749224fd2512970b2db0fb9325481698ff5817f.png | complex | <table><tr><td rowspan="2"><i>Diabetes</i></td><td rowspan="2"><i>Gender</i></td><td rowspan="2"><i>n</i></td><td colspan="3"><i>Box-counting FD (GrayScale)</i></td></tr><tr><td>Mean FD</td><td>95% CI</td><td><i>p</i><sup>†</sup></td></tr><tr><td rowspan="2">No</td><td>Female</td><td>71</td><td>2.4203</td><td>2.4164 - 2.4242</td><td rowspan="4">0.052</td></tr><tr><td>Male</td><td>95</td><td>2.4251</td><td>2.4217 - 2.4284</td></tr><tr><td rowspan="2">Yes</td><td>Female</td><td>12</td><td>2.4308</td><td>2.4214 - 2.4402</td></tr><tr><td>Male</td><td>11</td><td>2.4499</td><td>2.4401 - 2.4598</td></tr></table> |
f352d392710200946c50e1af4e88caf6158786301e0171e21b391e297aa66e22.png | simple | <table><tr><td> </td><td>CHD group (<i>n</i> = 45)</td><td>Healthy group (<i>n</i> = 15)</td><td><i>P</i> value</td></tr><tr><td>Age</td><td>59.24 ± 7.87</td><td>57.53 ± 4.47</td><td>0.304</td></tr><tr><td>Gender (male/female)</td><td>33/12</td><td>7/8</td><td>0.058</td></tr></table> |
1303fff38894a702373f96796dec19b28af722ab59ff59afe9532cc4719ee88f.png | complex | <table><tr><td>Predictor</td><td colspan="4">Digit span backward</td><td colspan="4">Letter-number sequencing</td></tr><tr><td></td><td>Df</td><td><i>F</i>-value</td><td><i>p</i>-value</td><td>η<sup>2</sup><sub><i>p</i></sub></td><td>Df</td><td><i>F</i>-value</td><td><i>p</i>-value</td><td>η<sup>2</sup><sub><i>p</i></sub></td></tr><tr><td>Group</td><td>1</td><td>0.56</td><td>0.46</td><td>0.11</td><td>1</td><td>0.64</td><td>0.43</td><td>0.10</td></tr><tr><td>Score</td><td>1</td><td>3.45</td><td>0.07</td><td>0.15</td><td>1</td><td>7.55</td><td>0.01</td><td>0.04</td></tr><tr><td>Group X Score</td><td>1</td><td>0.10</td><td>0.75</td><td>0.00</td><td>1</td><td>0.82</td><td>0.37</td><td>0.00</td></tr><tr><td>Residuals</td><td>33</td><td></td><td></td><td></td><td>33</td><td></td><td></td><td></td></tr></table> |
f30ae562cf6fb8777c4018602d19e224fbf0e38fedfbed4757a3564ccf429a66.png | complex | <table><tr><td></td><td colspan="3">No FamPlex</td><td colspan="3">With FamPlex</td></tr><tr><td>Rank</td><td>Entity Text</td><td>Count</td><td>% of Total</td><td>Entity Text</td><td>Count</td><td>% of Total</td></tr><tr><td>1</td><td>NF-kappaB</td><td>18,381</td><td>3.78</td><td>PKCzeta</td><td>222</td><td>0.24</td></tr><tr><td>2</td><td>ERK1/2</td><td>6137</td><td>1.26</td><td>RANTES</td><td>176</td><td>0.19</td></tr><tr><td>3</td><td>mTORC1</td><td>2753</td><td>0.57</td><td>DC</td><td>169</td><td>0.18</td></tr><tr><td>4</td><td>NFkappaB</td><td>2425</td><td>0.50</td><td>LDL</td><td>168</td><td>0.18</td></tr><tr><td>5</td><td>c-Jun</td><td>2369</td><td>0.49</td><td>IgE</td><td>152</td><td>0.17</td></tr><tr><td>6</td><td>antigen</td><td>1724</td><td>0.35</td><td>SDF-1-alpha</td><td>141</td><td>0.15</td></tr><tr><td>7</td><td>PDGF</td><td>1626</td><td>0.33</td><td>receptor</td><td>128</td><td>0.14</td></tr><tr><td>8</td><td>IKK</td><td>1542</td><td>0.32</td><td>beta1 integrin</td><td>127</td><td>0.14</td></tr><tr><td>9</td><td>c-Src</td><td>1362</td><td>0.28</td><td>p38alpha</td><td>126</td><td>0.14</td></tr><tr><td>10</td><td>histone H3</td><td>1347</td><td>0.28</td><td>CD4+</td><td>124</td><td>0.14</td></tr></table> |
9419fe23ddc68d08038a8c9124b9c5c473d5c714f2d0f69e9f2d40472c9b05a7.png | complex | <table><tr><td> </td><td colspan="3"><i>2008</i></td><td colspan="3"><i>2009</i></td><td colspan="3"><i>2010</i></td><td colspan="3"><i>2011</i></td></tr><tr><td><i>Province</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td><td><i>Cattle</i></td><td><i>Goats</i></td><td><i>Sheep</i></td></tr><tr><td>Limpopo</td><td>2.33</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>0.02</td><td> </td><td> </td><td> </td></tr><tr><td>Gauteng</td><td>12.60</td><td>91.97</td><td> </td><td> </td><td> </td><td> </td><td>0.38</td><td> </td><td>8.56</td><td> </td><td> </td><td> </td></tr><tr><td>Mpumalanga</td><td>23.89</td><td>1.98</td><td> </td><td> </td><td> </td><td>3.38</td><td> </td><td> </td><td>11.77</td><td> </td><td> </td><td> </td></tr><tr><td>Kwazulu-Natal</td><td> </td><td> </td><td> </td><td>7.22</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Northwest</td><td>4.54</td><td> </td><td>1.45</td><td> </td><td> </td><td> </td><td>0.68</td><td> </td><td>24.11</td><td> </td><td> </td><td> </td></tr><tr><td>Free State</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>17.22</td><td>29.38</td><td>187.97</td><td> </td><td> </td><td> </td></tr><tr><td>Eastern Cape</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>1.16</td><td>0.99</td><td>6.50</td><td>1.58</td><td>3.81</td><td>26.67</td></tr><tr><td>Northern Cape</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>5.07</td><td>8.22</td><td>344.18</td><td>0.06</td><td> </td><td>120.99</td></tr><tr><td>Western Cape</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td>38.69</td><td>15.49</td><td>12.54</td><td>2.16</td><td>108.18</td><td>25.45</td></tr></table> |
079715311bda10ed1cea9dcc55a6cb3a6ece45122cb4e2ec8504931c923d96a4.png | simple | <table><tr><td><i>Gene</i></td><td><i>Disease</i></td><td><i>Mode of </i><i>inheritance</i></td><td><i>Stroke mechanism</i></td></tr><tr><td><i>GAL</i></td><td><i>Fabry's disease</i></td><td><i>X-linked</i></td><td><i>Large-artery disease and small-vessel disease</i></td></tr><tr><td><i>NOTCH3</i></td><td><i>CADASIL</i></td><td><i>AD</i></td><td><i>Small-vassel disease</i></td></tr><tr><td><i>HBB</i></td><td><i>Sickle-cell disease</i></td><td><i>AR</i></td><td><i>Large-artery disease, small-vessel disease, haemodynamic insufficiency</i></td></tr><tr><td><i>CBS and others</i></td><td><i>Homocystinuria</i></td><td><i>AR</i></td><td><i>Large-artery disease, cardioembolism, small-vessel disease, arterial dissection</i></td></tr><tr><td><i>mtDNA</i></td><td><i>MELAS</i></td><td><i>Maternal</i></td><td><i>Complex (microvascular and neuronal factors)</i></td></tr><tr><td><i>FBN1</i></td><td><i>Marfan syndrome</i></td><td><i>AD</i></td><td><i>Cardioembolism and arterial dissection</i></td></tr><tr><td><i>COL3A1</i></td><td><i>Ehlers-Danlos syndrome type IV</i></td><td><i>AD</i></td><td><i>Arterial dissection</i></td></tr><tr><td><i>ABCC6</i></td><td><i>Pseudoxanthoma elasticum</i></td><td><i>AR</i></td><td><i>Large-artery disease and small-vessel disease</i></td></tr></table> |
2e9f15b9b04f3c98581f4c57a001a8f1fa4519d2e71d1341e1e4b59a69a9a5ff.png | complex | <table><tr><td rowspan="2">Fungi</td><td colspan="8">Minimum fungicidal concentrations of ethanol extract of <i>Cleome gynandra</i> in mg/ml</td><td colspan="2">Controls</td></tr><tr><td>0.5</td><td>0.25</td><td>0.125</td><td>0.0625</td><td>0.0313</td><td>0.0156</td><td>0.00781</td><td>0.00391</td><td>−ve ctrl</td><td>+ ctrl</td></tr><tr><td>Mc</td><td>Nfgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Nfgo</td></tr><tr><td>Tm</td><td>Nfgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Nfgo</td></tr><tr><td>Tr</td><td>Nfgo</td><td>Nfgo</td><td>Nfgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Fgo</td><td>Nfgo</td></tr></table> |
88091677bd29de7e8fd88b58e0eb1ed257493997ae57f50df166c358d225364d.png | simple | <table><tr><td>Testing completed</td><td><i>N</i> (%)</td></tr><tr><td>Actionable</td><td>92 (65%)</td></tr><tr><td>Not actionable or informative</td><td>35 (25%)</td></tr><tr><td>Informative</td><td>11 (8%)</td></tr><tr><td>No reportable results</td><td>2 (1%)</td></tr><tr><td>Test failed</td><td>1 (< 1%)</td></tr></table> |
764844cfbb1981fa3274cac0dff6391c03e174de7f1a2bd1a3aaf6202a7d35cf.png | complex | <table><tr><td colspan="2">Escala de risco de sangramento RIETE modificada</td></tr><tr><td>Variável</td><td>Pontos</td></tr><tr><td>Hemorragia maior recente (< 1 mês)</td><td>2</td></tr><tr><td>Creatinina > 1,2 mg/dL</td><td>1,5</td></tr><tr><td>Anemia</td><td>1,5</td></tr><tr><td>Câncer</td><td>1</td></tr><tr><td>Idade > 75 anos</td><td>5</td></tr><tr><td colspan="2">Risco baixo: 0; Risco intermediário: 1-4; Risco alto: > 4</td></tr></table> |
3fc65e06ca6c36f2c9f1dd26f3ab6fd9382af047a2d83d2a59f06fcf35cac3fa.png | complex | <table><tr><td></td><td colspan="3">Percentage reporting ‘never’ undertaking measure for reducing risk of violence</td><td></td></tr><tr><td></td><td>M</td><td>F</td><td>N</td><td>Significance χ<sup>2</sup></td></tr><tr><td>Check patient notes in advance</td><td>52</td><td>37</td><td>620</td><td>p<.001</td></tr><tr><td>Leave door ajar when seeing certain patients</td><td>80</td><td>67</td><td>604</td><td>p<.001</td></tr><tr><td>Accompanied when seeing certain patients</td><td>70</td><td>64</td><td>610</td><td>p<.05</td></tr><tr><td>Accompanied on visits to certain patients</td><td>77</td><td>65</td><td>610</td><td>p<.005</td></tr><tr><td>Leaving visit schedule with someone</td><td>48</td><td>25</td><td>618</td><td>p<.001</td></tr><tr><td>Carry personal alarm</td><td>95</td><td>77</td><td>583</td><td>p<.001</td></tr><tr><td>Attended self‐defence course</td><td>94</td><td>85</td><td>590</td><td>p<.005</td></tr></table> |
b8303fb9f5d52cac87ac16d9512c0a608f7076e87f0c92d333b19f7f97743dce.png | complex | <table><tr><td>Pt</td><td>Chromosome</td><td>Probes/libraries</td><td>Band localization</td><td>Genomic Localization (bp) (hg19)</td></tr><tr><td>1</td><td>8</td><td>AML1/ETO<sup>a</sup>WCP 1<sup>b</sup></td><td>designed for t(8;21)Whole chromosome paint library</td><td>–</td></tr><tr><td rowspan="2">2</td><td>2</td><td>WCP 2<sup>b</sup>CTD-2314L14<sup>c</sup>CTD-2599D22<sup>c</sup>ALK<sup>d</sup>CTD-3028D11 <sup>c</sup>CTD-2232H14<sup>c</sup>CTD-2566H13<sup>c</sup>CTD-2532N8<sup>c</sup>CTD-2371H10<sup>c</sup>CTD-2382F21<sup>c</sup>CTD-2052G24<sup>c</sup>CTD-3058K15<sup>c</sup></td><td>Whole chromosome paint library2p23.32p23.22p23.2–23.12p23.12p22.22p22.2–22.12p21.32p21.12p16.32p152p15–14</td><td>27,436,476–27,577,216 bp29,678,603–29,819,833 bp-31,532,615–31,667,611 bp36,717,490–36,828,693 bp38,563,970–38,725,504 bp42,157,290–42,301,116 bp46,582,036–46,715,607 bp48,326,711–48,434,143 bp61,463,234–61,600,608 bp64,034,477–64,232,972 bp</td></tr><tr><td>8</td><td>WCP 8<sup>b</sup>AML1/ETO<sup>a</sup>CTD-2341G19<sup>c</sup>CTD-2246G22<sup>c</sup>CTD-3245G9<sup>c</sup>CTD-2330N9<sup>c</sup></td><td>Whole chromosome paint library designed for t(8;21)8q21.138q21.38q21.38q21.3</td><td>-83,886,651–83,982,215 bp87,885,140–87,980,460 bp91,740,722–91,959,017 bp92,778,106–92,922,619 bp</td></tr></table> |
06e59ca022e490995b3744620905645031b87bcf76f076b54f513d84a7729a00.png | simple | <table><tr><td>FIRST GENE (REFSEQ ACCESSION NUMBER)</td><td>FIRST GENE (AHR BINDING SITES)</td><td>FIRST GENE (BINDING SITES OF OTHER TFS)</td><td>SECOND GENE (REFSEQ ACCESSION NUMBER)</td><td>SECOND GENE (AHR BINDING SITES)</td><td>SECOND GENE (BINDING SITES OF OTHER TFS)</td></tr><tr><td>NM_003928</td><td>-</td><td>-</td><td>NM_015582</td><td>n.d.*</td><td>n.d.*</td></tr><tr><td>NM_005334</td><td>-</td><td>NFKB</td><td>NM_003492</td><td>1</td><td>ATF3, SP2</td></tr><tr><td>NM_001643</td><td>-</td><td>PPARG2</td><td>NM_032174</td><td>1</td><td>-</td></tr><tr><td>NM_021642</td><td>1</td><td>-</td><td>NM_002155</td><td>-</td><td>NFKB</td></tr><tr><td>NM_005807</td><td>-</td><td>-</td><td>NM_003292</td><td>-</td><td>SP2</td></tr><tr><td>NM_006623</td><td>-</td><td>-</td><td>NM_005518</td><td>-</td><td>PPARG2</td></tr><tr><td>NM_002061</td><td>1</td><td>SP2</td><td>NM_000350</td><td>-</td><td>-</td></tr><tr><td>NM_144631</td><td>2</td><td>RFXANK</td><td>NM_002707</td><td>1</td><td>PPARG2</td></tr><tr><td>NM_005911</td><td>-</td><td>SP2, PPARG2</td><td>NM_000821</td><td>1</td><td>PPARG2</td></tr><tr><td>NM_016467</td><td>-</td><td>PPARG2</td><td>NM_000534</td><td>-</td><td>NFKB</td></tr><tr><td>NM_022173</td><td>1</td><td>-</td><td>NM_016297</td><td>1</td><td>RFXANK, SP2</td></tr><tr><td>NM_006590</td><td>1</td><td>-</td><td>NM_000542</td><td>-</td><td>NRF1, PPARG2</td></tr><tr><td>NM_005141</td><td>-</td><td>-</td><td>NM_000508</td><td>-</td><td>-</td></tr><tr><td>NM_000508</td><td>-</td><td>-</td><td>NM_000509</td><td>-</td><td>-</td></tr><tr><td>NM_007104</td><td>-</td><td>-</td><td>NM_003214</td><td>1</td><td>SP2</td></tr><tr><td>NM_138446</td><td>1</td><td>-</td><td>NM_006547</td><td>-</td><td>BHLHB2</td></tr><tr><td>NM_003235</td><td>-</td><td>-</td><td>NM_006748</td><td>-</td><td>-</td></tr><tr><td>NM_001261</td><td>-</td><td>NFKB</td><td>NM_004957</td><td>-</td><td>PBX1, SP2</td></tr><tr><td>NM_005564</td><td>-</td><td>NFKB</td><td>NM_024112</td><td>-</td><td>SP2</td></tr><tr><td>NM_005489</td><td>-</td><td>SP2</td><td>NM_001261</td><td>-</td><td>-</td></tr><tr><td>NM_004376</td><td>-</td><td>NFKB</td><td>NM_015960</td><td>-</td><td>PPARG2</td></tr><tr><td>NM_005271</td><td>5</td><td>BHLHB2</td><td>NM_019054</td><td>3</td><td>-</td></tr><tr><td>NM_001572</td><td>-</td><td>SP2, NFKB</td><td>NM_021924</td><td>1</td><td>SP2</td></tr><tr><td>NM_052854</td><td>-</td><td>SP2</td><td>NM_003646</td><td>-</td><td>SP2, PPARG2</td></tr><tr><td>NM_006169</td><td>-</td><td>RFXANK</td><td>NM_019021</td><td>1</td><td>PPARG2</td></tr><tr><td>NM_021640</td><td>-</td><td>-</td><td>NM_015665</td><td>-</td><td>NFKB</td></tr><tr><td>NM_003348</td><td>1</td><td>-</td><td>NM_014050</td><td>-</td><td>-</td></tr><tr><td>NM_002937</td><td>-</td><td>PPARG2</td><td>NM_001145</td><td>-</td><td>-</td></tr><tr><td>NM_006599</td><td>-</td><td>NFKB, BHLHB2</td><td>NM_000903</td><td>1</td><td>NRF1</td></tr><tr><td>NM_003562</td><td>1</td><td>RFXANK</td><td>NM_015528</td><td>1</td><td>NFKB, RFXANK</td></tr><tr><td>NM_002544</td><td>1</td><td>-</td><td>NM_006495</td><td>-</td><td>-</td></tr><tr><td>NM_018952</td><td>-</td><td>NFKB, RFXANK</td><td>NM_004502</td><td>2</td><td>RFXANK, BHLHB2</td></tr><tr><td>NM_007292</td><td>2</td><td>NFKB, BHLHB2</td><td>NM_001258</td><td>-</td><td>PPARG2</td></tr><tr><td>NM_005359</td><td>-</td><td>-</td><td>NM_016626</td><td>1</td><td>SP2</td></tr><tr><td>NM_032377</td><td>-</td><td>RFXANK</td><td>NM_001611</td><td>2</td><td>BHLHB2, PPARG2</td></tr><tr><td>NM_018270</td><td>2</td><td>-</td><td>NM_007346</td><td>-</td><td>RFXANK, BHLHB2</td></tr><tr><td>NM_002626</td><td>2</td><td>SP2</td><td>NM_004928</td><td>1</td><td>SP2</td></tr></table> |
2009d6ddd858d4051f6b3588c8295ec3e123c01400fc1c40703930ffe5d77978.png | simple | <table><tr><td>Plant Part</td><td>Subject of Study</td><td>Effect</td><td>Reference</td></tr><tr><td>ethyl acetate extract of the leaves</td><td>lung A549 cancer cells</td><td>mitochondrial-mediated apoptosis, cell cycle arrest at G<sub>1</sub> phase</td><td>[83]</td></tr><tr><td>ethyl acetate extract of the leaves</td><td>colon HT-29 and HCT-116 cancer cells</td><td>mitochondrial-mediated apoptosis, cell cycle arrest at G<sub>1</sub> phase, suppression of migration and invasion</td><td>[84]</td></tr><tr><td>water extract of the leaves</td><td>rat’s prostate</td><td>reduction of prostate size</td><td>[86]</td></tr><tr><td>ethanolic extract of the leaves</td><td>breast tissues of mice</td><td>prevention of DMBA-induced DNA damage</td><td>[87]</td></tr><tr><td>ethanolic extract of the leaves</td><td>DMBA/croton oil induced mice skin papillomagenesis</td><td>suppression of tumor initiation and promotion</td><td>[88]</td></tr><tr><td>ethanolic extract of the leaves</td><td>DMH induced colon cancer</td><td>reduction of ACF formation</td><td>[89]</td></tr><tr><td>ethanolic extract of the leaves</td><td>K562 chronic myeloid leukemia cells</td><td>induction of apoptosis</td><td>[85]</td></tr><tr><td>leaves boiled in water</td><td>metastatic breast cancer</td><td>stabilization of disease</td><td>[90]</td></tr><tr><td>ethyl acetate of the leaves</td><td>azoxymethane induced colon cancer</td><td>reduction of ACF formation</td><td>[91]</td></tr><tr><td>ethyl acetate of the leaves</td><td>colon HT-29 cancer cells</td><td>bioassay-guided isolation of annomuricin E and its apoptosis inducing effect</td><td>[91]</td></tr></table> |
86ce7f81a64b2bc71f48f0e8750b87f2ea25657acc9b0b0ac1670ad7aae27c86.png | simple | <table><tr><td>Number</td><td>Gender</td><td>Age</td><td>Treatment</td><td>Diagnosis of infection</td><td>Bacterial etiology</td><td>Days of infection detected after TACE and/or RFA</td><td>PCT on day of fever</td><td>Peak PCT within 7 days</td><td>Outcome of infection</td></tr><tr><td>1</td><td>M</td><td>57</td><td>TACE</td><td>Cholecystitis</td><td>Bile, <i>E. hirae</i></td><td>4</td><td>2.58</td><td>2.58</td><td>Cured</td></tr><tr><td>2</td><td>M</td><td>83</td><td>TACE</td><td>Pneumonia</td><td>—</td><td>5</td><td>0.72</td><td>0.72</td><td>Cured</td></tr><tr><td>3</td><td>M</td><td>55</td><td>TACE</td><td>UTI</td><td>—</td><td>4</td><td>0.23</td><td>2.40</td><td>Cured</td></tr><tr><td>4</td><td>M</td><td>75</td><td>TACE</td><td>Bacteremia, primary</td><td>Blood, <i>E. coli</i></td><td>2</td><td>1.55</td><td>1.70</td><td>Cured</td></tr><tr><td>5</td><td>M</td><td>79</td><td>TACE</td><td>UTI</td><td>—</td><td>3</td><td>1.19</td><td>1.19</td><td>Cured</td></tr><tr><td>6</td><td>M</td><td>73</td><td>TACE</td><td>Pneumonia</td><td>Sputum, <i>E. coli</i></td><td>7</td><td>0.21</td><td>0.24</td><td>Cured</td></tr><tr><td>7</td><td>F</td><td>77</td><td>Sequential TACE/RFA</td><td>Liver abscess</td><td>Blood, <i>E. casseliflavus</i></td><td>7</td><td>0.16</td><td>0.59</td><td>Transferred to another hospital</td></tr><tr><td>8</td><td>M</td><td>71</td><td>TACE</td><td>Bacteremia, cholangitis</td><td>Blood, <i>E. gallinarum</i></td><td>1</td><td>0.15</td><td>0.55</td><td>Cured</td></tr><tr><td>9</td><td>F</td><td>65</td><td>RFA</td><td>Bacteremia, RFA site cutaneous abscess</td><td>Blood, <i>S. aureus</i></td><td>1</td><td>0.08</td><td>0.17</td><td>Cured</td></tr></table> |
0480358c0e4b42e5ba9948a191c8ed18d9525fedcd35ee8e66fccaf1b5516435.png | simple | <table><tr><td>Type of Gholonj</td><td>Traditional term</td><td>Type of obstruction</td><td>Pathology</td></tr><tr><td>Inflammatory Gholonj</td><td>Gholonj-e-varami</td><td>Non mechanical</td><td>Inflammation in the intestinal wall or surrounding organs</td></tr><tr><td>Secretory Gholonj</td><td>Gholonj-e-balghami</td><td>Non mechanical</td><td>Accumulation of mucoid Phlegm in lumen of intestine</td></tr><tr><td>Flatulency Gholonj</td><td>Gholonj-e-reehi</td><td>Non mechanical</td><td>High gas accumulation in the lumen of intestine</td></tr><tr><td>Fecal Gholonj</td><td>Gholonj-e-sofli</td><td>Mechanical</td><td>Accumulation of fecal masses</td></tr><tr><td>Parasitic Gholonj</td><td>Gholonj-e-doodi</td><td>Mechanical</td><td>Aggregation of worms in the lumen of intestine</td></tr><tr><td>Torsion Gholonj</td><td>Gholonj-e-eltevaee</td><td>Mechanical</td><td>Intestinal torsion or bowel herniation</td></tr></table> |
cd381abe4a4c5d0e9cee93798a4b514d4b0d330038c02c5bbe2a62f07e57d996.png | complex | <table><tr><td></td><td colspan="3">TGF-β1 Release</td><td></td><td colspan="3">BDNF Release</td><td></td></tr><tr><td>LPS</td><td><i>E. coli</i></td><td></td><td><i>V. vulnificus</i></td><td></td><td><i>E. coli</i></td><td></td><td><i>V. vulnificus</i></td><td></td></tr><tr><td>(ng/mL)</td><td>(pg/mL)</td><td><i>n</i><sup>1</sup></td><td>(pg/mL)</td><td><i>n</i><sup>1</sup></td><td>(pg/mL)</td><td><i>n</i><sup>1</sup></td><td>(pg/mL)</td><td><i>n</i><sup>1</sup></td></tr><tr><td>0</td><td>319.7 ± 50.1</td><td>3</td><td>319.7 ± 50.1</td><td>3</td><td>0</td><td>2</td><td>0</td><td>2</td></tr><tr><td>0.1</td><td>424.3 ± 40.3</td><td>3</td><td>386 ± 16.0</td><td>2</td><td>5.1 ± 4.4</td><td>2</td><td>1.4 ± 0.8</td><td>2</td></tr><tr><td>1</td><td>363.3 ± 36</td><td>3</td><td>419 ± 66.9</td><td>3</td><td>18.4 ± 14.9</td><td>2</td><td>10.2 ± 6.2</td><td>2</td></tr><tr><td>10</td><td>318.7 ± 73.2</td><td>3</td><td>358 ± 50.1</td><td>3</td><td>6.9 ± 3.9</td><td>2</td><td>6.5 ± 5.5</td><td>2</td></tr><tr><td>100</td><td>333.3 ± 58.6</td><td>3</td><td>310 ± 51.6</td><td>3</td><td>6.6 ± 3.0</td><td>2</td><td>9.1 ± 4.7</td><td>2</td></tr><tr><td>1000</td><td>ND</td><td></td><td>352 ± 55.5</td><td>3</td><td>ND</td><td></td><td>7.5 ± 7.5</td><td>2</td></tr><tr><td>10,000</td><td>ND</td><td></td><td>613 ± 58.7</td><td>3</td><td>ND</td><td></td><td>0 ± 0</td><td>2</td></tr><tr><td>100,000</td><td>ND</td><td></td><td>973.5 ± 264.5 *</td><td>2</td><td>ND</td><td></td><td>2.05 ± 2.05</td><td>2</td></tr></table> |
a4387ae8e2afc2cb28086db0dbf096f8f595102fd891db733a30fc458297968e.png | complex | <table><tr><td colspan="2">Characteristics</td><td>Orifice involved (n=138)</td><td>Non-Orifice involved (n=1221)</td><td>Total (n=1359)</td><td>P</td></tr><tr><td colspan="2">Age (Mean ± SD)</td><td>65.1±10.5</td><td>63.4±11.7</td><td>63.5±11.6</td><td>0.087</td></tr><tr><td colspan="2">Follow-up, months (mean ± IQR)*</td><td>45.5 (9–68)</td><td>47.1 (9–70)</td><td>46.9 (9–69)</td><td>0.721</td></tr><tr><td colspan="2">No. Gender (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>M</td><td>119 (86.2)</td><td>1095 (89.7)</td><td>1214 (89.3)</td><td rowspan="2">0.214</td></tr><tr><td></td><td>F</td><td>19 (13.8)</td><td>126 (10.3)</td><td>145 (10.7)</td></tr><tr><td colspan="2">No.TCC tumor grade (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>G1</td><td>47 (34.1)</td><td>493 (40.4)</td><td>540 (39.7)</td><td></td></tr><tr><td></td><td>G2</td><td>36 (26.1)</td><td>286 (23.4)</td><td>322 (23.7)</td><td rowspan="2">0.067</td></tr><tr><td></td><td>G3</td><td>40 (29.0)</td><td>248 (20.3)</td><td>288 (21.2)</td></tr><tr><td></td><td>Unspecified</td><td>15 (10.8)</td><td>194 (15.9)</td><td>209 (15.4)</td><td></td></tr><tr><td colspan="2">No.TCC Tumor stage (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Ta</td><td>47 (34.1)</td><td>349 (28.6)</td><td>396 (29.1)</td><td></td></tr><tr><td></td><td>T1</td><td>59 (42.8)</td><td>520 (42.6)</td><td>579 (42.6)</td><td rowspan="2">0.565</td></tr><tr><td></td><td>≥T2</td><td>32 (23.2)</td><td>302 (24.7)</td><td>334 (24.6)</td></tr><tr><td></td><td>Unspecified</td><td>–</td><td>50 (4.1)</td><td>50 (3.7)</td><td></td></tr><tr><td colspan="2">Carsinoma in situ (CIS)(%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>CIS at initial diagnosis</td><td>6 (4.3)</td><td>42 (3.4)</td><td>48 (3.5)</td><td>0.584</td></tr><tr><td></td><td>CIS progression</td><td>3 (2.2)</td><td>22 (1.8)</td><td>25 (1.8)</td><td>0.758</td></tr><tr><td></td><td>Total CIS</td><td>9 (6.5)</td><td>64 (5.2)</td><td>73 (5.3)</td><td></td></tr><tr><td colspan="2">No. Tumor size (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Tumor < 3 cm</td><td>35 (25.4)</td><td>348 (28.5)</td><td>383 (28.2)</td><td></td></tr><tr><td></td><td>Tumor ≥ 3 cm</td><td>94 (68.1)</td><td>755 (61.8)</td><td>849 (62.5)</td><td>0.305</td></tr><tr><td></td><td>Unspecified</td><td>9 (6.5)</td><td>118 (9.7)</td><td>127 (9.3)</td><td></td></tr><tr><td colspan="2">No. Tumor number (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Solitary</td><td>99 (71.7)</td><td>728 (59.6)</td><td>827 (60.9)</td><td></td></tr><tr><td></td><td>Multiple</td><td>36 (26.1)</td><td>479 (39.2)</td><td>515 (37.9)</td><td>0.003</td></tr><tr><td></td><td>Unspecified</td><td>3 (2.2)</td><td>14 (1.1)</td><td>17 (1.2)</td><td></td></tr><tr><td colspan="2">Hydronephrosis (initial diagnosis)(%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Hydronephrosis±Atrophic kidney</td><td>46 (33.3)</td><td>170 (13.9)</td><td>216 (15.9)</td><td>0.0001</td></tr><tr><td colspan="2">Presence of UTUC (%)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Synchronous</td><td>14 (10.1)</td><td>8 (0.7)</td><td>22 (1.6)</td><td rowspan="2">0.0001</td></tr><tr><td></td><td>Metachronous*</td><td>7 (5.3)</td><td>11 (0.9)</td><td>18 (1.4)</td></tr></table> |
f6a1a42693b8d2c2a6159b0b9ff1852998db81a535a2c8fa272df325a3f59322.png | simple | <table><tr><td></td><td><i>E</i>/MPa</td><td><i>μ</i></td><td><i>α</i></td><td><i>K</i>/MPa</td></tr><tr><td>Theory values</td><td>2157</td><td>0.2</td><td>0.165872</td><td>0.875726</td></tr><tr><td>Identified values by GA</td><td>2135</td><td>0.182</td><td>0.171365</td><td>0.853471</td></tr><tr><td>Relative error of computing results for GA (%)</td><td>1.02</td><td>9</td><td>3.31</td><td>2.54</td></tr><tr><td>Identified values by FGA</td><td>2140</td><td>0.182</td><td>0.168442</td><td>0.853532</td></tr><tr><td>Relative error of computing results for FGA (%)</td><td>0.79</td><td>9</td><td>1.55</td><td>2.54</td></tr><tr><td>Identified values by IGA</td><td>2143</td><td>0.188</td><td>0.167812</td><td>0.854621</td></tr><tr><td>Relative error of computing results for IGA (%)</td><td>0.65</td><td>6</td><td>1.17</td><td>2.41</td></tr></table> |
084c7534c7cd4e5cabc9061a5dddba6c51f1ccf289662293bb6764b32cd8543e.png | complex | <table><tr><td>TOOL</td><td colspan="6">COHORT CHARACTERISTICS</td></tr><tr><td> </td><td>Disease</td><td>Number</td><td>Age (years)</td><td>Time since diagnosis/transplant</td><td>Race & gender</td><td>Country of validation</td></tr><tr><td>TRAQ [4]</td><td>Chronic diseases</td><td>192</td><td>16-26 (mean: 19.7)</td><td>NR</td><td>64% white, 56% female</td><td>USA</td></tr><tr><td>UNCTRxANSITION [17]</td><td>Chronic diseases</td><td>NR</td><td>12-22</td><td>NR</td><td>NR</td><td>USA</td></tr><tr><td>Self-management skills assessment guide [16]</td><td>Chronic diseases</td><td>49</td><td>11-19 (mean: 15.6)</td><td>NR</td><td>86% Caucasian</td><td>Canada</td></tr><tr><td>SCIS [8]</td><td>CF (with pancreatic insufficiency)</td><td>76 patients, 70 parents</td><td>4-17 (mean: 11.2)</td><td>NR</td><td>94% white</td><td>USA</td></tr><tr><td>Readiness questionnaire [9]</td><td>CF</td><td>36</td><td>NR</td><td>NR</td><td>NR</td><td>Canada</td></tr><tr><td>RTQ [10]</td><td>Renal transplant</td><td>48 patients, 32 parents</td><td>15-21 (mean: 18.6)</td><td>5.73 y</td><td>58% white, 29% black, 10% Hispanic</td><td>USA</td></tr><tr><td>TRS [2]</td><td>Liver transplant</td><td>71 patients, 58 parents</td><td>11-20 (mean: 15.6)</td><td>1-19 y (mean: 9.4 y)</td><td>56% female</td><td>USA</td></tr><tr><td>RCBRS [13]</td><td>T1DM</td><td>69</td><td>12-17 (mean: 14.2)</td><td>>6 months (mean: 5.49)</td><td>87% Caucasian</td><td>USA</td></tr><tr><td>McPherson et al. [14]</td><td>Sickle cell disease</td><td>69</td><td>14-21</td><td>NR</td><td>43% female</td><td>USA</td></tr><tr><td>TRQ [15]</td><td>HIV</td><td>65</td><td>9-25 (mean: 15.8)</td><td>1-17 years (mean: 10.5)</td><td>44% female, 45% Caucasian</td><td>USA</td></tr></table> |
fbcbde448d680a7d68352ef2dd7c6bec922a4fbdb6249c4998571a1c7c0fd98a.png | complex | <table><tr><td colspan="10">Phase II study</td></tr><tr><td rowspan="2">Patient</td><td rowspan="2">Treatment group</td><td colspan="8">Visit</td></tr><tr><td>BL</td><td>C2D1</td><td>C3D1</td><td>C4D1</td><td>D85</td><td>D180</td><td>D360</td><td>ET</td></tr><tr><td><i>1</i></td><td><i>Lipegfilgrastim</i></td><td><i>Neg</i></td><td><i>Neg</i></td><td><i>Neg</i></td><td><i>Neg</i></td><td><i>Pos</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td></tr><tr><td><i>2</i></td><td><i>Lipegfilgrastim</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>Pos</i></td><td><i>NA</i></td></tr><tr><td>3</td><td>Lipegfilgrastim</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>NA</td></tr><tr><td>4</td><td>Lipegfilgrastim</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Neg</td><td>NA</td></tr><tr><td>5</td><td>Lipegfilgrastim</td><td>Pos</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>Pos</td><td>Pos</td><td>Neg</td></tr><tr><td>6</td><td>Lipegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>7</td><td>Lipegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>8</td><td>Lipegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>Neg</td><td>NA</td></tr><tr><td>9</td><td>Lipegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td><i>10</i></td><td><i>Pegfilgrastim</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>Pos</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td></tr><tr><td>11</td><td>Pegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>12</td><td>Pegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td colspan="10">Phase III study</td></tr><tr><td rowspan="2">Patient</td><td rowspan="2">Treatment group</td><td colspan="8">Visit</td></tr><tr><td>S</td><td>BL</td><td>C2D1</td><td>C3D1</td><td>C4D1</td><td>D85</td><td>D180</td><td>D360</td></tr><tr><td><i>13</i></td><td><i>Lipegfilgrastim</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>Pos</i></td><td><i>Pos</i></td></tr><tr><td>14</td><td>Lipegfilgrastim</td><td>NA</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Pos</td><td>Neg</td><td>Neg</td><td>Neg</td></tr><tr><td>15</td><td>Lipegfilgrastim</td><td>NA</td><td>Pos</td><td>Pos</td><td>Neg</td><td>Neg</td><td>Neg</td><td>Neg</td><td>Neg</td></tr><tr><td>16</td><td>Lipegfilgrastim</td><td>NA</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td><i>17</i></td><td><i>Pegfilgrastim</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>NA</i></td><td><i>Pos</i></td></tr><tr><td>18</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>19</td><td>Pegfilgrastim</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>20</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>21</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>22</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><td>Neg</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>23</td><td>Pegfilgrastim</td><td>NA</td><td>Pos</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr></table> |
6bdd9b5e161bbf04a34227f1215b45d2b05308acae181ec60c1c56fe7152a32b.png | complex | <table><tr><td rowspan="3">Birth Weight for Gestational Age</td><td colspan="6">Dietary Pattern</td></tr><tr><td>Cereals, Eggs, and Cantonese Soups</td><td>Dairy</td><td>Fruits, Nuts, and Cantonese Desserts</td><td>Meats</td><td>Vegetables</td><td>Varied</td></tr><tr><td>(<i>n</i> = 1026)</td><td>(<i>n</i> = 1020)</td><td>(<i>n</i> = 799)</td><td>(<i>n</i> = 1066)</td><td>(<i>n</i> = 1383)</td><td>(<i>n</i> = 1160)</td></tr><tr><td>SGA (n, %)</td><td>89 (8.7)</td><td>80 (7.8)</td><td>54 (6.8)</td><td>86 (8.1)</td><td>94 (6.8)</td><td>102 (6.1)</td></tr><tr><td> Crude OR (95% CI)</td><td>1.00 (Reference)</td><td>0.90 (0.65-1.23)</td><td>0.76 (0.54-1.08)</td><td>0.92 (0.68-1.26)</td><td>0.77 (0.57-1.04)</td><td>0.69 (0.51-0.93) *</td></tr><tr><td> Adjusted OR (95% CI) <sup>1</sup></td><td>1.00 (Reference)</td><td>0.89 (0.65-1.22)</td><td>0.80 (0.56-1.14)</td><td>0.94 (0.69-1.28)</td><td>0.78 (0.58-1.06)</td><td>0.75 (0.56-1.01) </td></tr><tr><td> Adjusted OR (95% CI) <sup>2</sup></td><td>1.00 (Reference)</td><td>0.90 (0.66-1.23)</td><td>0.77 (0.54-1.09)</td><td>0.92 (0.68-1.26)</td><td>0.77 (0.57-1.04)</td><td>0.69 (0.51-0.93) *</td></tr><tr><td> Adjusted OR (95% CI) <sup>3</sup></td><td>1.00 (Reference)</td><td>0.89 (0.65-1.23)</td><td>0.72 (0.50-1.03)</td><td>0.94 (0.69-1.29)</td><td>0.76 (0.56-1.04)</td><td>0.70 (0.52-0.95) *</td></tr><tr><td> Adjusted OR (95% CI) <sup>4</sup></td><td>1.00 (Reference)</td><td>0.87 (0.63-1.21)</td><td>0.76 (0.53-1.10)</td><td>0.95 (0.69-1.30)</td><td>0.77 (0.56-1.05)</td><td>0.77 (0.57-1.04)</td></tr><tr><td>LGA (n, %)</td><td>103 (10.0)</td><td>106 (10.4)</td><td>96 (12.0)</td><td>87 (8.2)</td><td>147 (10.6)</td><td>194 (11.7)</td></tr><tr><td> Crude OR (95% CI)</td><td>1.00 (Reference)</td><td>1.04 (0.78-1.38)</td><td>1.22 (0.91-1.64)</td><td>0.80 (0.59-1.07)</td><td>1.07 (0.82-1.39)</td><td>1.19 (0.92-1.53)</td></tr><tr><td> Adjusted OR (95% CI) <sup>1</sup></td><td>1.00 (Reference)</td><td>1.03 (0.78-1.38)</td><td>1.17 (0.87-1.57)</td><td>0.78 (0.58-1.06)</td><td>1.04 (0.80-1.36)</td><td>1.11 (0.86-1.43)</td></tr><tr><td> Adjusted OR (95% CI) <sup>2</sup></td><td>1.00 (Reference)</td><td>1.03 (0.77-1.37)</td><td>1.21 (0.90-1.62)</td><td>0.79 (0.59-1.07)</td><td>1.08 (0.82-1.41)</td><td>1.19 (0.93-1.54)</td></tr><tr><td> Adjusted OR (95% CI) <sup>3</sup></td><td>1.00 (Reference)</td><td>1.04 (0.77-1.36)</td><td>1.22 (0.90-1.64)</td><td>0.77 (0.57-1.04)</td><td>1.06 (0.81-1.38)</td><td>1.17 (0.91-1.51)</td></tr><tr><td> Adjusted OR (95% CI) <sup>4</sup></td><td>1.00 (Reference)</td><td>1.01 (0.75-1.35)</td><td>1.14 (0.84-1.54)</td><td>0.75 (0.56-1.02) </td><td>1.03 (0.79-1.36)</td><td>1.10 (0.85-1.42)</td></tr></table> |
f19782f1f8947e4c27ab993149e238697b050b5c8f4d61d51354213a55008b3e.png | complex | <table><tr><td rowspan="2">mRNA co-expression MET vs.</td><td colspan="2">ALL Stage</td><td colspan="2">Stage I-II</td><td colspan="2">Stage III-IV</td></tr><tr><td>Pearson's Correlation</td><td><i>p</i>-value</td><td>Pearson's Correlation</td><td><i>p</i>-value</td><td>Pearson's Correlation</td><td><i>p</i>-value</td></tr><tr><td><i>ALDH1A1</i></td><td>0.06</td><td>0.008</td><td>0.05</td><td>0.058</td><td>-0.03</td><td>0.736</td></tr><tr><td><i>ALDH1A3</i></td><td>0.22</td><td><0.001</td><td>0.21</td><td><0.001</td><td>0.40</td><td><0.001</td></tr><tr><td><i>CD44</i></td><td>0.02</td><td>0.381</td><td>0.01</td><td>0.857</td><td>0.04</td><td>0.637</td></tr><tr><td><i>CD133</i></td><td>0.30</td><td><0.001</td><td>0.31</td><td><0.001</td><td>0.40</td><td><0.001</td></tr><tr><td><i>KLF4</i></td><td>0.10</td><td><0.001</td><td>0.11</td><td><0.001</td><td>0.12</td><td>0.181</td></tr><tr><td><i>MYC</i></td><td>0.14</td><td><0.001</td><td>0.15</td><td><0.001</td><td>0.17</td><td>0.055</td></tr><tr><td><i>NANOG</i></td><td>-0.04</td><td>0.064</td><td>-0.02</td><td>0.560</td><td>0.01</td><td>0.895</td></tr><tr><td><i>NOTCH1</i></td><td>0.17</td><td><0.001</td><td>0.16</td><td><0.001</td><td>0.43</td><td><0.001</td></tr><tr><td><i>NOTCH3</i></td><td>0.06</td><td>0.010</td><td>0.02</td><td>0.449</td><td>0.22</td><td>0.017</td></tr><tr><td><i>OCT4</i></td><td>0.02</td><td>0.325</td><td>0.00</td><td>0.888</td><td>0.35</td><td><0.001</td></tr><tr><td><i>SOX2</i></td><td>0.00</td><td>0.882</td><td>0.01</td><td>0.730</td><td>-0.05</td><td>0.609</td></tr><tr><td><i>STAT3</i></td><td>-0.03</td><td>0.156</td><td>-0.05</td><td>0.078</td><td>-0.05</td><td>0.558</td></tr><tr><td><i>BMI1</i></td><td>-0.16</td><td><0.001</td><td>-0.17</td><td><0.001</td><td>-0.20</td><td>0.023</td></tr></table> |
f2c045feb4c0d601e6c9d8050f1ff9426cc921916c0c7812a586600fcf67c8b8.png | simple | <table><tr><td>Main objectives of participating in the training</td><td>n</td><td>%</td></tr><tr><td>To learn about psychosomatic medicine/biopsychosocial models</td><td>28</td><td>25%</td></tr><tr><td>To learn didactical teaching methods (such as interactive learning and presenting lectures)</td><td>23</td><td>20%</td></tr><tr><td>To acquire practical skills for daily clinical practice (such as communication, role playing, patient interviewing, family interviewing, and creating genograms)</td><td>18</td><td>16%</td></tr><tr><td>To learn about doctor-patient communication skills</td><td>12</td><td>11%</td></tr><tr><td>To improve patient management</td><td>9</td><td>8%</td></tr><tr><td>To learn about the diagnosis and treatment of specific psychosomatic disorders</td><td>8</td><td>6%</td></tr><tr><td>To address administrative and sustainability issues in the curriculum</td><td>5</td><td>4%</td></tr><tr><td>To learn how to use Balint group methods</td><td>5</td><td>4%</td></tr><tr><td>To share experiences with other doctors/acquire more self-experience</td><td>4</td><td>3%</td></tr><tr><td>Other</td><td>2</td><td>2%</td></tr></table> |
0be0175547bca70f32887bc3e8d2b2b1cfbaaf899818fed20c0ccb93d24ac648.png | complex | <table><tr><td></td><td colspan="2">Intervention, n = 114</td><td colspan="2">Comparison, n = 60</td></tr><tr><td>IPV status</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>0</td><td>9</td><td><i>8</i></td><td>6</td><td><i>10</i></td></tr><tr><td>3–6</td><td>11</td><td><i>10</i></td><td>2</td><td><i>3</i></td></tr><tr><td>≥ 7</td><td>93</td><td><i>82</i></td><td>48</td><td><i>80</i></td></tr><tr><td>Missing</td><td>1</td><td><i>1</i></td><td>4</td><td><i>7</i></td></tr><tr><td>When partner last inflicted abuse</td><td></td><td></td><td></td><td></td></tr><tr><td> <i>Abused in last 12 months</i><i>(n = 121)</i></td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>1</td><td><i>1</i></td><td>0</td><td><i>0</i></td></tr><tr><td>3–6</td><td>3</td><td><i>4</i></td><td>1</td><td><i>2</i></td></tr><tr><td>≥ 7</td><td>76</td><td><i>95</i></td><td>39</td><td><i>95</i></td></tr><tr><td>Missing</td><td>0</td><td><i>0</i></td><td>1</td><td><i>2</i></td></tr><tr><td> <i>Abused>12 months ago </i><i>(n = 33)</i></td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>4</td><td><i>20</i></td><td>3</td><td><i>23</i></td></tr><tr><td>3–6</td><td><i>3</i></td><td><i>15</i></td><td>0</td><td><i>0</i></td></tr><tr><td>≥ 7</td><td>13</td><td><i>65</i></td><td>8</td><td><i>62</i></td></tr><tr><td>Missing</td><td><i>0</i></td><td><i>0</i></td><td>2</td><td><i>15</i></td></tr><tr><td> <i>A partner has never abused me</i><i>(n = 15)</i></td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>4</td><td><i>36</i></td><td>2</td><td><i>50</i></td></tr><tr><td>3–6</td><td>2</td><td><i>18</i></td><td>1</td><td><i>25</i></td></tr><tr><td>≥ 7</td><td>4</td><td><i>36</i></td><td>0</td><td><i>0</i></td></tr><tr><td>Missing</td><td>1</td><td><i>9</i></td><td>1</td><td><i>25</i></td></tr><tr><td>Depressed (EPDS ≥ 13)</td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>32</td><td><i>28</i></td><td>26</td><td><i>43</i></td></tr><tr><td>Yes</td><td>81</td><td><i>71</i></td><td>33</td><td><i>55</i></td></tr><tr><td>Missing</td><td>1</td><td></td><td>1</td><td></td></tr></table> |
331ec58ea2cdbe6921286757898d95b08b09570b1432d5ed4fc1f3b4600f3db5.png | complex | <table><tr><td>Item</td><td colspan="3">Patient Ratings</td><td colspan="3">Clinician Ratings</td></tr><tr><td></td><td>Localized</td><td>Metastatic</td><td>Total</td><td>Nurse</td><td>Physician</td><td>Total</td></tr><tr><td>PAIN</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have pain</td><td>2.4</td><td>1.8</td><td>2.1</td><td>3.8</td><td>4.0</td><td>3.9</td></tr><tr><td> Pain interfered with my daily activities</td><td>2.0</td><td>1.8</td><td>1.9</td><td>3.8</td><td>3.2</td><td>3.5</td></tr><tr><td> I have pain in my back</td><td>2.0</td><td>1.1</td><td>1.5</td><td>2.4</td><td>2.6</td><td>2.5</td></tr><tr><td> I have discomfort or pain in my stomach area</td><td>1.7</td><td>1.8</td><td>1.8</td><td>2.6</td><td>1.8</td><td>2.2</td></tr><tr><td>BREATHING</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have been short of breath</td><td>0.7</td><td>2.5</td><td>1.7</td><td>3.8</td><td>3.0</td><td>3.3</td></tr><tr><td>WEAKNESS</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have felt weak</td><td>2.2</td><td>2.8</td><td>2.5</td><td>4.0</td><td>3.6</td><td>3.8</td></tr><tr><td>MOOD</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I worry that my condition will get worse</td><td>3.0</td><td>3.1</td><td>3.1</td><td>3.6</td><td>2.4</td><td>3.0</td></tr><tr><td> I have emotional ups and downs</td><td>2.6</td><td>2.2</td><td>2.4</td><td>3.6</td><td>1.6</td><td>2.6</td></tr><tr><td> I feel depressed</td><td>2.6</td><td>2.0</td><td>2.3</td><td>3.6</td><td>1.8</td><td>2.7</td></tr><tr><td> I am able to enjoy life<sup>2</sup></td><td>2.2</td><td>2.8</td><td>2.5</td><td>3.8</td><td>3.0</td><td>3.4</td></tr><tr><td>SLEEP</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have had trouble sleeping</td><td>2.5</td><td>2.1</td><td>2.3</td><td>3.6</td><td>2.4</td><td>3.0</td></tr><tr><td>WEIGHT LOSS</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I am losing weight</td><td>1.4</td><td>2.0</td><td>1.7</td><td>3.5</td><td>3.6</td><td>3.6</td></tr><tr><td>COGNITIVE</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have difficulty remembering things</td><td>1.6</td><td>1.6</td><td>1.6</td><td>3.5</td><td>2.0</td><td>2.7</td></tr><tr><td> I have trouble concentrating</td><td>1.7</td><td>2.1</td><td>1.9</td><td>3.5</td><td>2.0</td><td>2.7</td></tr><tr><td>FATIGUE</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I feel fatigued</td><td>2.3</td><td>2.0</td><td>2.2</td><td>3.8</td><td>3.8</td><td>3.8</td></tr><tr><td> I have a lack of energy</td><td>2.4</td><td>2.5</td><td>2.5</td><td>3.8</td><td>3.2</td><td>3.4</td></tr><tr><td> I feel tired</td><td>2.3</td><td>2.1</td><td>2.2</td><td>3.8</td><td>3.0</td><td>3.3</td></tr><tr><td> I have trouble starting things because I am tired</td><td>1.7</td><td>2.1</td><td>1.9</td><td>3.0</td><td>2.0</td><td>2.5</td></tr><tr><td> I have trouble finishing things because I am tired</td><td>1.9</td><td>2.4</td><td>2.2</td><td>3.0</td><td>2.0</td><td>2.5</td></tr><tr><td>APPETITE</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have lacked appetite</td><td>1.5</td><td>1.9</td><td>1.7</td><td>3.6</td><td>3.6</td><td>3.6</td></tr><tr><td> I have a good appetite<sup>3</sup></td><td>2.5</td><td>3.1</td><td>2.8</td><td>3.0</td><td>3.4</td><td>3.2</td></tr><tr><td>INCONTINENCE (BOWEL OR BLADDER)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have control of my bowels<sup>4</sup></td><td>2.4</td><td>2.5</td><td>2.5</td><td>2.2</td><td>1.6</td><td>1.9</td></tr><tr><td> I have trouble moving my bowels</td><td>1.6</td><td>1.3</td><td>1.5</td><td>3.6</td><td>2.2</td><td>2.9</td></tr><tr><td> I urinate more frequently than usual<sup>5</sup></td><td>1.7</td><td>1.7</td><td>1.7</td><td>2.2</td><td>1.6</td><td>1.9</td></tr><tr><td> I have difficulty urinating</td><td>1.6</td><td>1.2</td><td>1.4</td><td>2.4</td><td>1.6</td><td>2.0</td></tr><tr><td>OTHER SYMPTOMS</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> I have had chills</td><td>1.4</td><td>1.8</td><td>1.6</td><td>3.4</td><td>2.6</td><td>3.0</td></tr><tr><td> I have had fevers</td><td>1.3</td><td>1.5</td><td>1.4</td><td>3.8</td><td>3.0</td><td>3.4</td></tr><tr><td> I have had sweats<sup>6</sup></td><td>1.2</td><td>1.1</td><td>1.1</td><td>3.8</td><td>3.2</td><td>3.5</td></tr><tr><td> I feel lightheaded</td><td>1.6</td><td>1.7</td><td>1.6</td><td>2.8</td><td>2.6</td><td>2.7</td></tr><tr><td> I am bothered by blood in my urine<sup>7</sup></td><td>n/a</td><td>n/a</td><td>n/a</td><td>2.0</td><td>2.8</td><td>2.4</td></tr></table> |
5e2d89443dfd3f10d94c97c629203b3367a12136f0d392c9e89f3a2b8a3e1e02.png | simple | <table><tr><td>Target genes</td><td>Primers</td></tr><tr><td>MMP1</td><td>Forward primer: 5′-aagccatcacttaccttgcact-3′</td></tr><tr><td></td><td>Reverse primer: 5′-tcagagaccttggtgaatgtca-3′</td></tr><tr><td>MMP9</td><td>Forward primer: 5′-ctggagacctgagaaccaa-3′</td></tr><tr><td></td><td>Reverse primer: 5′-actgctcaaagcctccacaaga-3′</td></tr><tr><td>β-Actin</td><td>Forward primer: 5′-ctccatcctggcctcgctgt-3′</td></tr><tr><td></td><td>Reverse primer: 5′-gctgtcaccttcaccgttcc-3′</td></tr></table> |
0648fcfbd71405fb94fb090228756acf8dfcbd4342a0319a766b44f2cb11eaf0.png | complex | <table><tr><td rowspan="2">Metal</td><td colspan="2">SQGs (mg/kg)-Freshwater Sediment (Upstream)</td><td colspan="3">Percentage of Samples Exceeding SQGs (%)</td></tr><tr><td>TEL</td><td>PEL</td><td><TEL</td><td>TEL-PEL</td><td>>PEL</td></tr><tr><td>Cu</td><td>35.7</td><td>197</td><td>80.0</td><td>16.0</td><td>4.00</td></tr><tr><td>Zn</td><td>123</td><td>315</td><td>80.0</td><td>8.00</td><td>12.0</td></tr><tr><td>Cr</td><td>37.3</td><td>90.0</td><td>32.0</td><td>44.0</td><td>24.0</td></tr><tr><td>Ni</td><td>18.0</td><td>35.9</td><td>16.0</td><td>68.0</td><td>16.0</td></tr><tr><td>Pb</td><td>35.0</td><td>91.3</td><td>96.0</td><td>4.0</td><td>0.00</td></tr><tr><td>Cd</td><td>0.60</td><td>3.53</td><td>96.0</td><td>4.00</td><td>0.00</td></tr><tr><td rowspan="2">Metal</td><td colspan="2">SQGs (mg/kg)-Marine Sediment (Downstream)</td><td colspan="3">Percentage of Samples Exceeding SQGs (%)</td></tr><tr><td>TEL</td><td>PEL</td><td><TEL</td><td>TEL-PEL</td><td>>PEL</td></tr><tr><td>Cu</td><td>18.7</td><td>108</td><td>73.3</td><td>20.0</td><td>6.67</td></tr><tr><td>Zn</td><td>124</td><td>271</td><td>93.3</td><td>0.00</td><td>6.67</td></tr><tr><td>Cr</td><td>52.3</td><td>160</td><td>73.3</td><td>26.7</td><td>0.00</td></tr><tr><td>Ni</td><td>15.9</td><td>42.8</td><td>46.7</td><td>53.3</td><td>0.00</td></tr><tr><td>Pb</td><td>30.2</td><td>112</td><td>86.7</td><td>13.3</td><td>0.00</td></tr><tr><td>Cd</td><td>0.68</td><td>4.21</td><td>93.3</td><td>6.67</td><td>0.00</td></tr></table> |
3cf5cd8592533f8a4de912f0e011fac32465a9bbeedbb9eb5c3185796e6a935f.png | complex | <table><tr><td></td><td>Hue</td><td>Saturation</td><td>Value</td><td>Red</td><td>Green</td><td>Blue</td><td>Grey</td></tr><tr><td colspan="8">Low Resolution Normalised Images</td></tr><tr><td>Expert 1</td><td>90.8%</td><td>82.5%</td><td>85.8%</td><td>85.8%</td><td>87.0%</td><td>87.0%</td><td>90.8%</td></tr><tr><td>Expert 2</td><td>91.0%</td><td>82.8%</td><td>84.5%</td><td>84.5%</td><td>86.3%</td><td>86.3%</td><td>90.0%</td></tr><tr><td>Expert 3</td><td>91.0%</td><td>80.3%</td><td>87.5%</td><td>87.5%</td><td>89.3%</td><td>88.8%</td><td>92.5%</td></tr><tr><td>Expert 4</td><td>91.8%</td><td>84.0%</td><td>84.3%</td><td>84.3%</td><td>86.0%</td><td>86.0%</td><td>89.8%</td></tr><tr><td colspan="8">High Resolution Normalised Images</td></tr><tr><td>Expert 1</td><td>83.3%</td><td>75.0% *</td><td>85.8%</td><td>87.8%</td><td>87.3%</td><td>87.5%</td><td>87.3%</td></tr><tr><td>Expert 2</td><td>84.5%</td><td>74.8% *</td><td>86.0%</td><td>87.5%</td><td>87.5%</td><td>86.3%</td><td>87.5%</td></tr><tr><td>Expert 3</td><td>85.0%</td><td>75.3% *</td><td>87.5%</td><td>88.5%</td><td>89.5%</td><td>87.8%</td><td>89.5%</td></tr><tr><td>Expert 4</td><td>82.3%</td><td>74.0% *</td><td>83.8%</td><td>85.8%</td><td>85.3%</td><td>86.0%</td><td>85.3%</td></tr></table> |
f8b0cbeb92fcfb014be783b3f8984cde54540e9019be0cf9ca7ebbb293f384c9.png | simple | <table><tr><td>Factor</td><td>Cronbach’s α</td><td>Item-to-subscale correlation</td><td>Subscale-to-total correlation</td></tr><tr><td>1 Psychological expression</td><td>0.92</td><td>0.58–0.75</td><td>0.92</td></tr><tr><td>2 Changes in self and family</td><td>0.82</td><td>0.49–0.62</td><td>0.73</td></tr><tr><td>3 Physical symptoms</td><td>0.81</td><td>0.31–0.64</td><td>0.80</td></tr><tr><td>4 Social and family connectedness</td><td>0.73</td><td>0.30–0.73</td><td>0.39</td></tr><tr><td>5 Fatalism</td><td>0.88</td><td>0.67–0.84</td><td>0.39</td></tr><tr><td>6 Religion and faith</td><td>0.64</td><td>0.17–0.66</td><td>0.02</td></tr><tr><td>7 Self-query</td><td>0.62</td><td>0.27–0.47</td><td>0.59</td></tr><tr><td>8 Coping style</td><td>0.59</td><td>0.34–0.50</td><td>0.12</td></tr></table> |
4e142f104ccfcfe908ba373cf59582dcba11c1b26ebdfade27cf918580132b90.png | simple | <table><tr><td></td><td>Transobturator Sling</td><td>Single-Incision Sling</td><td>p value</td></tr><tr><td>Preoperative daily pads usage (mean)</td><td>4.45±0.82 (3-6)</td><td>4.25±0.78 (3-6)</td><td>p=0.495</td></tr><tr><td>Postoperative daily pads usage (mean)</td><td>0.30±0.57 (0-2)</td><td>0.55±0,68 (0-2)</td><td>p=0.192</td></tr><tr><td>Postoperatively, the number of patients with</td><td>15 / 20</td><td>11 / 20</td><td>p=0.190</td></tr><tr><td>no pad usage (n / all patients)</td><td></td><td></td><td></td></tr><tr><td>Subjective cure rates</td><td>75%</td><td>55%</td><td>p=0.190</td></tr></table> |
87273a619111f411ae5d5e41cb8b31f0fc06c8deaaad76a175281122a4c7d793.png | simple | <table><tr><td>Treatment options</td><td>Mean cost per child in A$2010-2011 (95%CI)</td><td>Mean number of QALYs (95%CI)</td><td>Mean incremental number of QALYs vs no treatment</td><td>ICER</td></tr><tr><td>No treatment</td><td>0</td><td>11.57</td><td>-</td><td>-</td></tr><tr><td></td><td></td><td>(10.24; 13.06)</td><td></td><td></td></tr><tr><td>Non-directive counselling</td><td>2125</td><td>12.59</td><td>1.02</td><td>2083</td></tr><tr><td></td><td>(1927; 2335)</td><td>(11.62; 13.57)</td><td></td><td></td></tr><tr><td>TF-CBT only</td><td>2097</td><td>12.85</td><td>1.28</td><td>1638</td></tr><tr><td></td><td>(1904; 2302)</td><td>(11.98; 13.74)</td><td></td><td></td></tr><tr><td>TF-CBT + SSRI (sertraline)</td><td>2271</td><td>12.92</td><td>1.35</td><td>1682</td></tr><tr><td></td><td>(2070; 2478)</td><td>(12.01; 13.78)</td><td></td><td></td></tr></table> |
f4f6864fac6d96462493e472b370f217a78fae6350edad5a76a932c07b32370f.png | complex | <table><tr><td></td><td>Total dust</td><td>Respirable crystalline silica dust</td></tr><tr><td colspan="3">Long-term average exposure (mg/m<sup>3</sup>)</td></tr><tr><td>Mean (SD)</td><td>6.1 (4.8)</td><td>0.27 (0.19)</td></tr><tr><td>Median (min.–max.)</td><td>4.8 (0–36.7)</td><td>0.22 (0–1.16)</td></tr><tr><td colspan="3">Highest exposure ever* (mg/m<sup>3</sup>)</td></tr><tr><td>Mean (SD)</td><td>23.5 (11.6)</td><td>0.73 (0.34)</td></tr><tr><td>Median (min.–max.)</td><td>23.8 (0–65.8)</td><td>0.74 (0–1.95)</td></tr><tr><td colspan="3">Cumulative exposure (mg/m<sup>3</sup>-year)</td></tr><tr><td>Mean (SD)</td><td>226.4 (171.0)</td><td>7.32 (5.22)</td></tr><tr><td>Median (min.–max.)</td><td>183.7 (0–861.7)</td><td>6.20 (0–26.6)</td></tr><tr><td colspan="3">Exposure duration (years)</td></tr><tr><td>Mean (SD)</td><td colspan="2">27.8 (7.4)</td></tr><tr><td>Median (min.–max.)</td><td colspan="2">27.8 (1.1–46.4)</td></tr></table> |
86a7497e5e02f10f56feb2b03a8cc5ca57c480ae3ac1b3b75ff0c9924c79d6eb.png | simple | <table><tr><td> </td><td>Qigong</td><td>Exercise therapy</td><td>Study population</td></tr><tr><td> </td><td>Mean (±SD)</td><td>Mean (±SD)</td><td>Mean (±SD)</td></tr><tr><td> </td><td><i>N</i> = 10 8 female, 2 male</td><td><i>N</i> = 10 8 female, 2 male</td><td><i>N</i> = 122 107 female, 25 male</td></tr><tr><td>Age (years)</td><td>40.6 (±10.3)</td><td>44.6 (±9.3)</td><td>45.6 (±10.7)</td></tr><tr><td>VAS baseline (mm)</td><td>60.1 (±13.1)</td><td>56.5(±12.2)</td><td>56.2 (±14.1)</td></tr><tr><td>Pain duration (years)</td><td>3.9 (±1.2)</td><td>3.1 (±1.6)</td><td>3.2 (±1.6)</td></tr></table> |
3057f875a42ffd8f16480aefc9af48e00479d5fb02364549b7624b6acf303ec6.png | complex | <table><tr><td rowspan="2">Stage</td><td colspan="2">OS</td></tr><tr><td>HR(95% CI)</td><td>P-value<sup>‡</sup></td></tr><tr><td>T2</td><td></td><td></td></tr><tr><td> RT+Surg Vs Surg</td><td>1.085(0.745-1.581)</td><td>0.671</td></tr><tr><td> Surg+RT Vs Surg</td><td>0.776(0.400-1.507)</td><td>0.454</td></tr><tr><td>T3</td><td></td><td></td></tr><tr><td> RT+Surg Vs Surg</td><td>0.615(0.475-0.797)</td><td>0.000***</td></tr><tr><td> Surg+RT Vs Surg</td><td>0.597(0.387-0.921)</td><td>0.020*</td></tr></table> |
a0917c19192b0c2d99ff77b178df953c81a27254d6d962644764b1da962877fc.png | simple | <table><tr><td>General descriptives</td><td>∑ Tot.</td><td>Sand</td><td>Canopy-forming algae</td><td>Seagrass aboveground</td><td>Seagrass belowground</td></tr><tr><td><i>Traditional numerical variables</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td># of species </td><td>36</td><td>17</td><td>26</td><td>29</td><td>23</td></tr><tr><td># of species only in one habitat</td><td>10</td><td>2</td><td>4</td><td>3</td><td>1</td></tr><tr><td># of species found in all habitats</td><td>13</td><td></td><td></td><td></td><td></td></tr><tr><td>Abundance dm<sup>-3</sup> (Mean ± SD)</td><td></td><td>18.4±11.5</td><td>2733.8±1624.8</td><td>5974.7±4154.3</td><td>110.0±44.2</td></tr><tr><td><i>Functional variables</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td># of modalities expressed (Total)</td><td>55</td><td>51</td><td>55</td><td>54</td><td>53</td></tr><tr><td># of modalities (Mean ±SD)</td><td></td><td>44.3±3.1</td><td>48.5±1.8</td><td>50.6±3.4</td><td>51.7±1.1</td></tr><tr><td># of species per modality (Mean)</td><td></td><td>2.4</td><td>3.7</td><td>4.5</td><td>4.2</td></tr></table> |
1ca9bc188f7fab99cd22846dc4e259585f82c1d63e72dd1d45438ba33ca3124a.png | complex | <table><tr><td> </td><td colspan="2">Shift admitted</td><td rowspan="2"><i>p</i> value</td></tr><tr><td> </td><td>Day</td><td>Night</td></tr><tr><td>Mortality (%)</td><td>3.5</td><td>4.3</td><td>0.57</td></tr><tr><td>ICU admission (%)</td><td>2.2</td><td>3.2</td><td>0.32</td></tr><tr><td>Mean length of stay (days)</td><td>5.1</td><td>5.7</td><td>0.18<sup><i>∗</i></sup></td></tr><tr><td>Readmission, 30 days (%)</td><td>8.1</td><td>7.1</td><td>0.60</td></tr><tr><td>Need for surgery (%)</td><td>43.5</td><td>39.6</td><td>0.26</td></tr></table> |
8dec3eb22597635e108f62179161fef2290b1da61d6217d498e924670ce965c2.png | complex | <table><tr><td></td><td></td><td></td><td colspan="7">Bivariate Correlations</td></tr><tr><td></td><td><i>M</i></td><td><i>SD</i></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr><tr><td>DERS total</td><td>83.76</td><td>25.80</td><td>_</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DBT Skills Use</td><td>1.92</td><td>.40</td><td>-.36**</td><td>_</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Dysfunctional Coping</td><td>1.61</td><td>.55</td><td>.69**</td><td>.03</td><td>_</td><td></td><td></td><td></td><td></td></tr><tr><td><i>SRP Subscales:</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Interpersonal manipulation</td><td>1.96</td><td>.69</td><td>.26*</td><td>-.27*</td><td>.26*</td><td>_</td><td></td><td></td><td></td></tr><tr><td>Callous affect</td><td>1.91</td><td>.68</td><td>.35*</td><td>-.24*</td><td>.43*</td><td>.63**</td><td>_</td><td></td><td></td></tr><tr><td>Erratic lifestyle</td><td>2.18</td><td>.72</td><td>.39**</td><td>-.14</td><td>.44**</td><td>.52**</td><td>.70**</td><td>_</td><td></td></tr><tr><td>Criminal tendencies</td><td>1.29</td><td>.39</td><td>.27*</td><td>-.13</td><td>.29*</td><td>.51**</td><td>.57**</td><td>.56**</td><td>_</td></tr></table> |
7e3837f30f1d4ebcbfd79845f283e0e2d835a23602f2c89e708c65e1de39fb9a.png | complex | <table><tr><td></td><td colspan="3">Knowledge</td><td colspan="3">Tick check frequency</td></tr><tr><td></td><td>β</td><td>S.E.</td><td><i>p</i>value</td><td>β<sup>a</sup></td><td>S.E.</td><td><i>p</i>value</td></tr><tr><td>(Intercept)</td><td>0.522</td><td>0.265</td><td>0.049</td><td>−0.034</td><td>0.241</td><td>0.886</td></tr><tr><td><i>t2</i> (reference: <i>t1</i>)</td><td>1.430</td><td>0.310</td><td>0.000</td><td>0.599</td><td>0.252</td><td>0.017</td></tr><tr><td>Leaflet (reference: game)</td><td>0.232</td><td>0.337</td><td>0.499</td><td>0.624</td><td>0.305</td><td>0.052</td></tr><tr><td>Control group (reference: game)</td><td>0.032</td><td>0.330</td><td>0.924</td><td>1.040</td><td>0.305</td><td>0.002</td></tr><tr><td>Knowing somebody with Lyme</td><td>0.604</td><td>0.178</td><td>0.001</td><td>0.710</td><td>0.178</td><td>0.000</td></tr><tr><td>Having had lectures on ticks</td><td>0.535</td><td>0.184</td><td>0.004</td><td>0.215</td><td>0.176</td><td>0.222</td></tr><tr><td><i>t2</i><sup>a</sup>Leaflet</td><td>0.735</td><td>0.409</td><td>0.072</td><td>−0.601</td><td>0.291</td><td>0.039</td></tr><tr><td><i>t2</i><sup>a</sup>Control</td><td>−0.532</td><td>0.335</td><td>0.112</td><td>−0.347</td><td>0.298</td><td>0.244</td></tr><tr><td><i>t2</i><sup>a</sup>Knowing somebody with Lyme</td><td>−0.022</td><td>0.316</td><td>0.946</td><td>−0.270</td><td>0.253</td><td>0.286</td></tr><tr><td><i>t2</i><sup>a</sup>Having had lectures on ticks</td><td>−0.380</td><td>0.289</td><td>0.188</td><td>0.035</td><td>0.241</td><td>0.883</td></tr></table> |
4ac955a1270cbdc606749bf5e15a83fc8ddd88da4e574a0c93aca6046e736af9.png | complex | <table><tr><td>Haplotype</td><td colspan="2">Honduras (n = 77)</td><td colspan="2">Nicaragua (n = 33)</td></tr><tr><td> </td><td>Number of samples</td><td>Frequency</td><td>Number of samples</td><td>Frequency</td></tr><tr><td>I</td><td>22</td><td>0.29</td><td>9</td><td>0.27</td></tr><tr><td>II</td><td>2</td><td>0.03</td><td>0</td><td>0</td></tr><tr><td>III</td><td>1</td><td>0.01</td><td>1</td><td>0.03</td></tr><tr><td>IV</td><td>2</td><td>0.03</td><td>0</td><td>0</td></tr><tr><td>V</td><td>6</td><td>0.08</td><td>0</td><td>0</td></tr><tr><td>VI</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>VII</td><td>7</td><td>0.09</td><td>1</td><td>0.03</td></tr><tr><td>VIII</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>IX</td><td>5</td><td>0.06</td><td>6</td><td>0.18</td></tr><tr><td>X</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XI</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XII</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XIII</td><td>5</td><td>0.06</td><td>0</td><td>0</td></tr><tr><td>XIV</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XV</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XVI</td><td>7</td><td>0.09</td><td>2</td><td>0.06</td></tr><tr><td>XVII</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XVIII</td><td>6</td><td>0.08</td><td>0</td><td>0</td></tr><tr><td>XIX</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XX</td><td>2</td><td>0.03</td><td>0</td><td>0</td></tr><tr><td>XXI</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XXII</td><td>1</td><td>0.01</td><td>0</td><td>0</td></tr><tr><td>XXIII</td><td>1</td><td>0.01</td><td>1</td><td>0.03</td></tr><tr><td>XXIV</td><td>0</td><td>0</td><td>1</td><td>0.03</td></tr><tr><td>XXV</td><td>0</td><td>0</td><td>12</td><td>0.36</td></tr></table> |
fa9c01f387cb2635d5eba414b4d664b59867405bf2c9158fa0b4df7f3018e139.png | simple | <table><tr><td>Origin</td><td>Region</td><td>Isolate serial number</td><td>Total number of isolates</td><td>Number of genotypes</td><td>Number of polymorphic loci</td><td>Polymorphic loci (%)</td></tr><tr><td>Rich Kser Wallal</td><td>Rich Errachidia</td><td>7</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Rich Kser Aït Said</td><td>Rich Errachidia</td><td>20</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Rich Kser Tabia</td><td>Rich Errachidia</td><td>27; 30</td><td>2</td><td>-</td><td>5</td><td>13.51</td></tr><tr><td>Demnate</td><td>Demnate</td><td>42</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Ziz Kser Bouya Jerf</td><td>Jerf Erfoud</td><td>57-58</td><td>2</td><td>-</td><td>6</td><td>16.22</td></tr><tr><td>Jerf</td><td>Jerf Erfoud</td><td>66</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Erfoud Hay Lagmbita</td><td>Jerf Erfoud</td><td>76-80; 88</td><td>6</td><td>6</td><td>20</td><td>54.05</td></tr><tr><td>Erfoud Masoudia</td><td>Jerf Erfoud</td><td>91-92</td><td>2</td><td>-</td><td>5</td><td>13.51</td></tr><tr><td>Errachidia Aïne Zerka</td><td>Rich Errachidia</td><td>116-117</td><td>2</td><td>-</td><td>9</td><td>24.32</td></tr><tr><td>Toudra Tinghir</td><td>Tinghir</td><td>119; 121</td><td>2</td><td>-</td><td>14</td><td>37.84</td></tr><tr><td>Ziz Errachidia</td><td>Ziz</td><td>122</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Over all</td><td>-</td><td>-</td><td>21</td><td>21</td><td>35</td><td>94.59</td></tr></table> |
283c0bb6afe6e6e47cac5550a8a8e4434c51f6c954dd550b4be39b213f56a85e.png | simple | <table><tr><td> </td><td>1st set</td><td>1st set CV</td><td>2nd set</td><td>2st set CV</td><td>SDw</td><td>CV (%)</td><td>ICC</td></tr><tr><td>Rrs5 (kPa/L/sec)</td><td>1.11 ± 0.24</td><td>8.04 ± 11.9</td><td>1.10 ± 0.18</td><td>7.68 ± 4.0</td><td>0.37</td><td>4.64</td><td>0.88 (0.76–0.94)</td></tr><tr><td>Rrs10 (kPa/L/sec)</td><td>0.90 ± 0.17</td><td>5.33 ± 2.70</td><td>0.90 ± 0.13</td><td>5.88 ± 4.05</td><td>0.31</td><td>4.29</td><td>0.87 (0.74–0.94)</td></tr><tr><td>Xrs5 (kPa/L/sec)</td><td>−0.43 ± 0.12</td><td>10.4 ± 5.74</td><td>−0.41 ± 0.10</td><td>14.0 ± 7.74</td><td>0.29</td><td>5.78</td><td>0.81 (0.61–0.91)</td></tr><tr><td>Xrs10 (kPa/L/sec)</td><td>−0.23 ± 0.06</td><td>11.7 ± 6.01</td><td>−0.25 ± 0.09</td><td>14.4 ± 8.44</td><td>0.31</td><td>10.35</td><td>0.73 (0.46–0.87)</td></tr><tr><td>AX (kPa/L)</td><td>3.62 ± 1.36</td><td>11.2 ± 6.70</td><td>3.28 ± 1.28</td><td>14.4 ± 10.08</td><td>0.98</td><td>11.21</td><td>0.85 (0.71–0.93)</td></tr><tr><td>Rf (Hz)</td><td>22.0 ± 2.0</td><td>4.90 ± 2.81</td><td>21.6 ± 2.2</td><td>4.64 ± 4.47</td><td>1.37</td><td>3.36</td><td>0.76 (0.52–0.88)</td></tr></table> |
a40041c9515bd29fb010191b42395d5f99a9c23a4e5dd016272081c234d5f8ca.png | complex | <table><tr><td>HCC parameters</td><td>Number of patients</td><td>miR-940 (−)</td><td>miR-940 (+)</td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Male</td><td>38</td><td>31</td><td>7</td><td rowspan="2">0.515</td><td rowspan="2">0.473</td></tr><tr><td> Female</td><td>8</td><td>5</td><td>3</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> ≥50 years old</td><td>36</td><td>29</td><td>7</td><td rowspan="2">0.080</td><td rowspan="2">0.777</td></tr><tr><td> <50 years old</td><td>10</td><td>7</td><td>3</td></tr><tr><td>Etiology</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> HBV+</td><td>38</td><td>30</td><td>8</td><td rowspan="2">0.000</td><td rowspan="2">1.000</td></tr><tr><td> HBV−</td><td>8</td><td>6</td><td>2</td></tr><tr><td>Cirrhosis</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Positive</td><td>37</td><td>31</td><td>6</td><td rowspan="2">1.934</td><td rowspan="2">0.164</td></tr><tr><td> Negative</td><td>9</td><td>5</td><td>4</td></tr><tr><td>AFP (ng/mL)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> ≥400</td><td>29</td><td>22</td><td>7</td><td rowspan="2">0.021</td><td rowspan="2">0.885</td></tr><tr><td> <400</td><td>17</td><td>14</td><td>3</td></tr><tr><td>Tumor size</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> ≥5 cm</td><td>26</td><td>21</td><td>5</td><td rowspan="2">0.012</td><td rowspan="2">0.913</td></tr><tr><td> <5 cm</td><td>20</td><td>15</td><td>5</td></tr><tr><td>TNM stage</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> I-II</td><td>25</td><td>18</td><td>7</td><td rowspan="2">0.584</td><td rowspan="2">0.445</td></tr><tr><td> III-IV</td><td>21</td><td>18</td><td>3</td></tr><tr><td>Edmondson grade</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> I-II</td><td>22</td><td>13</td><td>9</td><td rowspan="2">7.076</td><td rowspan="2">0.008<sup><i>∗∗</i></sup></td></tr><tr><td> III-IV</td><td>24</td><td>23</td><td>1</td></tr><tr><td>Tumor microsatellite or multiple tumors</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>20</td><td>19</td><td>1</td><td rowspan="2">4.217</td><td rowspan="2">0.040<sup><i>∗</i></sup></td></tr><tr><td> No</td><td>26</td><td>17</td><td>9</td></tr><tr><td>Vascular invasion</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>15</td><td>15</td><td>0</td><td rowspan="2">4.432</td><td rowspan="2">0.035<sup><i>∗</i></sup></td></tr><tr><td> No</td><td>31</td><td>21</td><td>10</td></tr><tr><td>Recurrence and metastasis</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>29</td><td>26</td><td>3</td><td rowspan="2">4.313</td><td rowspan="2">0.038<sup><i>∗</i></sup></td></tr><tr><td> No</td><td>17</td><td>10</td><td>7</td></tr></table> |
542d0003d337c533a10b8ed9d0c5b0cddbc3b4ccc0be5b0f9aeb6932ff70ef28.png | simple | <table><tr><td>Target protein or pathway</td><td>Drug</td><td>CHIKV IC<sub>50</sub> (μM)</td><td>WST-1 IC<sub>50</sub> (μM)</td><td>Therapeutic index</td></tr><tr><td>Fatty acid synthesis</td><td>TOFA</td><td>0.15</td><td>> 60*</td><td>NT</td></tr><tr><td> </td><td>Orlistat</td><td>0.82</td><td>8.67</td><td>10.57</td></tr><tr><td> </td><td>Cerulenin</td><td>3</td><td>7.57</td><td>2.53</td></tr><tr><td>vATPase</td><td>Bafilomycin</td><td>0.000334</td><td>0.003*</td><td>NT</td></tr><tr><td>CLK1</td><td>AnnH18</td><td>1.02</td><td>9.19</td><td>9.04</td></tr><tr><td> </td><td>AnnH14</td><td>1.55</td><td>10.55</td><td>6.79</td></tr><tr><td> </td><td>KH-CB19</td><td>3.36</td><td>10.93</td><td>3.26</td></tr><tr><td>KAT5</td><td>(15:3)-Anacardic acid</td><td>0.58</td><td>2.68</td><td>4.65</td></tr><tr><td>Calmodulin signalling</td><td>TAE684</td><td>0.15</td><td>2.07</td><td>14.28</td></tr><tr><td> </td><td>Pimozide</td><td>0.28</td><td>19.18</td><td>69.75</td></tr><tr><td> </td><td>Perphenazine</td><td>0.63</td><td>24.23</td><td>38.28</td></tr><tr><td> </td><td>6-Hydroxyflavone</td><td>2.6</td><td>> 60</td><td>NT</td></tr><tr><td> </td><td>Prenylamine</td><td>2.39</td><td>16.53</td><td>6.91</td></tr><tr><td> </td><td>Felodipine</td><td>3.24</td><td>12.08</td><td>3.73</td></tr><tr><td>FLT4</td><td>Alsterpaullone</td><td>0.002</td><td>44.38*</td><td>NT</td></tr><tr><td> </td><td>Pazopanib</td><td>0.13</td><td>1.32*</td><td>NT</td></tr><tr><td> </td><td>Axitinib</td><td>0.3</td><td>0.34*</td><td>NT</td></tr><tr><td> </td><td>Tivozanib</td><td>0.8</td><td>8.34*</td><td>NT</td></tr><tr><td> </td><td>Sorafenib</td><td>1.11</td><td>18.24</td><td>16.42</td></tr><tr><td> </td><td>Linifanib</td><td>2.15</td><td>> 60</td><td>NT</td></tr></table> |
a2c59155f139f52f26df26f664df45179cf13d431a93c78c82bd45e3c47725a5.png | simple | <table><tr><td>Country</td><td>Year</td><td>Sample size</td><td>Age range</td><td>Both genders</td><td>Male</td><td>Female</td></tr><tr><td>Southern China</td><td>2008</td><td>446</td><td>55</td><td>19.1%</td><td>14.5%</td><td>24.4%</td></tr><tr><td>Taiwan [10]</td><td>2000</td><td>1937</td><td>65+</td><td>32.5%</td><td>30.1%</td><td>34.9%</td></tr><tr><td>Japan [11]</td><td>2006</td><td>572</td><td>55-75</td><td>45.8%</td><td>41.7%</td><td>52.5%</td></tr><tr><td>Australia [12]</td><td>2001</td><td>1263</td><td>65+</td><td>43%</td><td>35%</td><td>52%</td></tr><tr><td>New Zealand [13]</td><td>1997</td><td>814</td><td>65+</td><td>36.1%</td><td>24.7%</td><td>43.7%</td></tr><tr><td>Indonesia [14]</td><td>1996</td><td>204</td><td>60-75</td><td>25.0%</td><td>24.7%</td><td>25.2%</td></tr><tr><td>Korea [15]</td><td>2000</td><td>2188</td><td>50+</td><td>30.2%</td><td>28.5%</td><td>30.7%</td></tr><tr><td>Malaysia [16]</td><td>2005</td><td>60</td><td>50+</td><td>83.1%</td><td>NA</td><td>NA</td></tr></table> |
f2bca81ba9afac2b18b04121b5e66979437c6d65e3bd42cc2fae164f4925d5ea.png | simple | <table><tr><td>Name BRE</td><td>5′ primer (5′-3′)</td><td>3′ primer (5′-3′)</td><td>size (bp)</td></tr><tr><td>7–13</td><td>GATGAGCTCATGCGAAAGTGAAGGTGGTCCCCAG</td><td>TGAAGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>1278</td></tr><tr><td>9–13</td><td>GAGCTCTCGAACCTCTCTTTCCTATCTC</td><td>AGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>695</td></tr><tr><td>10–13</td><td>GAGCTCTGGAGCTGAGCCTGGAGAGAAG</td><td>AGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>530</td></tr><tr><td>12–13</td><td>GAGCTCTAGGCCATCAGACAGCTCTGAG</td><td>AGATCTAGCAAGGAGGAACTGGAGATGTCA</td><td>127</td></tr><tr><td>9</td><td>GAGCTCTCGAACCTCTCTTTCCTATCTC</td><td>AGATCTCTTCTCTCCAGGCTCAGCTCCA</td><td>189</td></tr><tr><td>9–10</td><td>GAGCTCTCGAACCTCTCTTTCCTATCTC</td><td>AGATCTCCCTCATCTCTCCTTGCAGCT</td><td>253</td></tr><tr><td>9–11</td><td>GAGCTCTCGAACCTCTCTTTCCTATCTC</td><td>AGATCTAGGCCCTCAAATTCCTCAGAG</td><td>348</td></tr></table> |
c0abab8f54c68f201176ce26c58c54d6cc21f21b90e272915d3a84cc8d2e7929.png | simple | <table><tr><td>Age (years)</td><td>Male [positive/total (%)]</td><td>Female [positive/total (%)]</td><td>Total [positive/total (%)]</td></tr><tr><td>17-27</td><td>7/452 (1.54)</td><td>10/585 (1.7)</td><td>17/1037 (1.63)</td></tr><tr><td>28-36</td><td>4/326 (1.22)</td><td>7/365 (1.91)</td><td>11/691 (1.59)</td></tr><tr><td>37-53</td><td>6/137 (4.37)</td><td>8/293 (2.73)</td><td>14/430 (3.25)</td></tr><tr><td>54-79</td><td>5/180 (2.77)</td><td>5/350 (1.42)</td><td>10/530 (1.88)</td></tr><tr><td>Total</td><td>22/1095 (2.0)</td><td>30/1593 (1.88)</td><td>52/2688 (1.93)</td></tr></table> |
d15d2831b523652439349c196dceb12a5e384fe078aab52302472d3730a89276.png | simple | <table><tr><td>Characteristics</td><td>PA group (<i>N</i> = 145)</td><td>Non-PA group (<i>N</i> = 79)</td><td><i>P</i> value</td></tr><tr><td>Age, years (mean ± SD)</td><td>67.6 ± 11.7</td><td>65.0 ± 12.6</td><td>0.128</td></tr><tr><td>Sex (male/female)</td><td>94 (64.8%)/51 (35.2%)</td><td>54 (68.4%)/25 (31.6%)</td><td>0.659</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>21.6 ± 2.7</td><td>21.8 ± 2.7</td><td>0.538</td></tr><tr><td>Aims (preoperative/palliative)</td><td>82 (56.6%)/63 (43.4%)</td><td>44 (55.7%)/35 (44.3%)</td><td>1.000</td></tr><tr><td>Diabetes mellitus</td><td>21 (14.5%)</td><td>11 (13.9%)</td><td>1.000</td></tr><tr><td>WBC (×1000), (/mm<sup>3</sup>)</td><td>8.1 ± 3.2</td><td>7.5 ± 2.7</td><td>0.198</td></tr><tr><td>ANC (×1000), (/mm<sup>3</sup>)</td><td>5.8 ± 3.0</td><td>5.2 ± 2.5</td><td>0.124</td></tr><tr><td>CRP<sup>∗</sup> (mg/dL) </td><td>4.6 ± 6.6</td><td>2.4 ± 3.4</td><td>0.001</td></tr><tr><td>Potassium (mEq/L)</td><td>3.9 ± 0.5</td><td>3.9 ± 0.8</td><td>0.556</td></tr><tr><td>Abdominal pain</td><td>112 (77.2%)</td><td>54 (68.4%)</td><td>0.154</td></tr><tr><td>Abdominal tenderness<sup>∗</sup></td><td>66 (45.5%)</td><td>22 (27.8%)</td><td>0.010</td></tr><tr><td>Degree of obstruction (total/subtotal)</td><td>42 (29.0%)/103 (71.0%)</td><td>19 (24.1%)/60 (75.9%)</td><td>0.530</td></tr><tr><td>Mechanical ileus<sup>∗</sup></td><td>80 (55.2%)</td><td>24 (27.8%)</td><td><0.001</td></tr><tr><td>Carcinomatosis peritonei</td><td>18 (12.4%)</td><td>7 (8.9%)</td><td>0.509</td></tr><tr><td>Obstruction site </td><td> </td><td> </td><td>0.857</td></tr><tr><td> Ascending colon</td><td>3 (2.1%)</td><td>2 (2.5%)</td><td> </td></tr><tr><td> Hepatic flexure</td><td>8 (5.5%)</td><td>5 (6.3%)</td><td> </td></tr><tr><td> Transverse colon</td><td>3 (2.1%)</td><td>0 (0.0%)</td><td> </td></tr><tr><td> Splenic flexure</td><td>7 (4.8%)</td><td>5 (6.3%)</td><td> </td></tr><tr><td> Descending colon</td><td>8 (5.5%)</td><td>5 (6.3%)</td><td> </td></tr><tr><td> Rectosigmoid colon</td><td>116 (80.0%)</td><td>62 (78.5%)</td><td> </td></tr></table> |
64bc28821b94914e887cb426d37ec475df6ce03a56f85738eb41c596f6754a0f.png | complex | <table><tr><td>Outcomes</td><td>Group</td><td>LS mean ± SE<sup>a</sup></td><td>Difference<sup>b</sup> (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td colspan="5">Primary outcome</td></tr><tr><td colspan="5"> Total VSCs</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>0.115 ± 0.078</td><td>−0.246</td><td rowspan="2">0.002</td></tr><tr><td>Placebo</td><td>0.362 ± 0.081</td><td>(−0.395 to 0.098)</td></tr><tr><td rowspan="2">30 min</td><td>Test</td><td>0.173 ± 0.086</td><td>−0.136</td><td rowspan="2">0.199</td></tr><tr><td>Placebo</td><td>0.309 ± 0.090</td><td>(−0.348 to 0.075)</td></tr><tr><td colspan="5">Secondary outcomes</td></tr><tr><td colspan="5"> H<sub>2</sub>S</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>−0.085 ± 0.083</td><td>−0.349</td><td rowspan="2">< 0.001</td></tr><tr><td>Placebo</td><td>0.263 ± 0.086</td><td>(−0.506 to 0.192)</td></tr><tr><td rowspan="2">30 min</td><td>Test</td><td>0.056 ± 0.080</td><td>−0.171</td><td rowspan="2">0.066</td></tr><tr><td>Placebo</td><td>0.226 ± 0.084</td><td>(−0.353 to 0.012)</td></tr><tr><td colspan="5"> CH<sub>3</sub>SH</td></tr><tr><td rowspan="2">10 min</td><td>Test</td><td>−0.635 ± 0.129</td><td>−0.044</td><td rowspan="2">0.747</td></tr><tr><td>Placebo</td><td>−0.591 ± 0.134</td><td>(−0.321 to 0.233)</td></tr><tr><td rowspan="2">30 min</td><td>Test</td><td>−1.070 ± 0.141</td><td>−0.265</td><td rowspan="2">0.163</td></tr><tr><td>Placebo</td><td>−0.806 ± 0.149</td><td>(−0.641 to 0.112)</td></tr></table> |
b8de75b48e892672b3916de50cdc5896345c87048443f040ff624f66e88f9937.png | complex | <table><tr><td>Dependent variable</td><td>Independent variable</td><td>Estimate</td><td>Standard error</td><td>95% CI</td><td><i>P</i></td></tr><tr><td rowspan="4">SF-BP</td><td>Migraine (yes vs. no)</td><td>−8.93</td><td>1.40</td><td>−6.20 to −11.67</td><td><0.001</td></tr><tr><td>HAMD (one-point increment)</td><td>−1.20</td><td>0.10</td><td>−1.00 to − 1.40</td><td><0.001</td></tr><tr><td>HADS-A (one-point increment)</td><td>−0.59</td><td>0.19</td><td>−0.22 to −0.96</td><td><0.01</td></tr><tr><td>Educational years (one-year increment)</td><td>0.90</td><td>0.29</td><td>1.47 to 0.32</td><td><0.01</td></tr><tr><td rowspan="7">PS</td><td>Migraine (yes vs. no)</td><td>1.33</td><td>0.23</td><td>1.78 to 0.89</td><td><0.001</td></tr><tr><td>HAMD (one-point increment)</td><td>0.19</td><td>0.02</td><td>0.22 to 0.16</td><td><0.001</td></tr><tr><td>HADS-A (one-point increment)</td><td>0.12</td><td>0.03</td><td>0.18 to 0.06</td><td>< 0.001</td></tr><tr><td>Educational years (one-year increment)</td><td>−0.13</td><td>0.05</td><td>−0.03 to −0.23</td><td>0.01</td></tr><tr><td>Married (yes vs. no)</td><td>0.53</td><td>0.21</td><td>0.95–0.12</td><td>0.01</td></tr><tr><td>Age (one-year increment)</td><td>0.03</td><td>0.01</td><td>0.05 to 0.004</td><td>0.02</td></tr><tr><td>Anxiety disorders (yes vs. no)</td><td>0.52</td><td>0.24</td><td>1.00 to 0.05</td><td>0.03</td></tr></table> |
0ae8713bf8f50b03cf94637bda1d22a94b5009ede302c31fed83098dbcb179e6.png | complex | <table><tr><td rowspan="2">Coal samples</td><td colspan="4">Atomic concentration of elements/%</td><td colspan="2">(O/C) ratio/%</td></tr><tr><td>C 1s</td><td>O 1s</td><td>N 1s</td><td>S 2p</td><td>Elemental analysis</td><td>XPS analysis</td></tr><tr><td>Beizao lignite</td><td>80.34</td><td>18.22</td><td>1.44</td><td>/</td><td>20.61</td><td>22.68</td></tr><tr><td>Daliuta long flame coal</td><td>84.37</td><td>14.17</td><td>0.94</td><td>0.52</td><td>16.02</td><td>16.80</td></tr><tr><td>Yushuwan gas coal</td><td>87.68</td><td>11.5</td><td>0.82</td><td>/</td><td>12.03</td><td>13.12</td></tr><tr><td>Xinjulong fat coal</td><td>89.11</td><td>8.88</td><td>1.72</td><td>0.29</td><td>7.15</td><td>9.97</td></tr><tr><td>Wugou coking coal</td><td>88.41</td><td>9.08</td><td>1.83</td><td>0.68</td><td>5.50</td><td>10.27</td></tr><tr><td>Yangquan anthracite</td><td>89.18</td><td>9.05</td><td>1.34</td><td>0.43</td><td>2.52</td><td>10.15</td></tr></table> |
5f3af768bbf1c34e534d5b8238e53d892caf406b32903d034e53d8b3e9369a3d.png | simple | <table><tr><td>Variable</td><td>N</td><td>R Pearson Correlation</td><td>Level of significance</td></tr><tr><td>Organizational culture and organizational commitment</td><td>165</td><td>0.419</td><td>0.027</td></tr></table> |
4fc091c5306b84d46f985a610ca757d681847e014a63ab91a6c99e4505e4d451.png | complex | <table><tr><td>Variable</td><td><i>b</i></td><td>Wald</td><td>OR</td><td>95% CI for OR</td></tr><tr><td>Unreasonable illegitimate Tasks</td><td>0.53*</td><td>6.69</td><td>1.69</td><td>[1.14–2.52]</td></tr><tr><td>Role Conflict</td><td>0.08</td><td>0.33</td><td>1.08</td><td>[0.83–1.40]</td></tr><tr><td>Control over Work Pace</td><td>−0.44**</td><td>15.48</td><td>.64</td><td>[0.52–0.80]</td></tr><tr><td>Exhaustion</td><td>0.59**</td><td>11.24</td><td>1.81</td><td>[1.28–2.55]</td></tr><tr><td>Administrative Tasks</td><td>0.004</td><td>0.55</td><td>1.00</td><td>[0.99–1.02]</td></tr><tr><td>Gender</td><td>0.02</td><td>0.006</td><td>1.02</td><td>[0.69–1.50]</td></tr><tr><td>Age</td><td>−0.07</td><td></td><td>0.93</td><td>[0.85–1.02]</td></tr><tr><td colspan="5">-2log likelihood 619.37**Cox & Snell <i>R</i><sup><i>2</i></sup> .107Nagelkerke <i>R</i><sup><i>2</i></sup> .144</td></tr></table> |
eef7a9f43a6580a735c4f990951b12c8f14a07f36cc7d3bc9a35d18104838cca.png | simple | <table><tr><td>RSV</td><td>Influenza A (H1N1) virus</td></tr><tr><td>Age <6 months</td><td>Age <5 years</td></tr><tr><td>History of prematurity</td><td>Chronic lung disease</td></tr><tr><td>Chronic lung disease</td><td>Congenital heart disease</td></tr><tr><td>Congenital heart disease</td><td>Immunocompromised conditions</td></tr><tr><td>Viral coinfection</td><td></td></tr></table> |
bd20983cb54b176880e92b35d650c6996de964660186746ad436ca0f57ecd565.png | simple | <table><tr><td>Group</td><td>Sub group</td><td>Gender</td><td>Age (years ± <i>SD</i>)</td><td>Verbal memory (score ± <i>SD</i>)</td><td>O&M (years ± <i>SD</i>)</td></tr><tr><td>Gamers</td><td>Early blind</td><td>4 m/4 f</td><td>24.00 ± 6.76</td><td>81.13 ± 15.29</td><td>14.25 ± 7.78</td></tr><tr><td></td><td>Late blind</td><td>5 m/2 f</td><td>29.86 ± 7.34</td><td>72.43 ± 18.16</td><td>1.0 ± 0.00<sup>*</sup></td></tr><tr><td></td><td>Subgroup totals/means</td><td>9 m/6 f</td><td>26.73 ± 7.42</td><td>77.07 ± 16.69</td><td>8.07 ± 8.78</td></tr><tr><td>Directed navigators</td><td>Early blind</td><td>4 m/3 f</td><td>28.29 ± 9.05</td><td>87.86 ± 6.82</td><td>10.43 ± 9.91</td></tr><tr><td></td><td>Late blind</td><td>4 m/3 f</td><td>31.71 ± 10.45</td><td>83.43 ± 11.49</td><td>1.0 ± 0.00<sup>*</sup></td></tr><tr><td></td><td>Subgroup totals/means</td><td>8 m/6 f</td><td>30.00 ± 9.56</td><td>85.64 ± 9.36</td><td>5.71 ± 8.32</td></tr><tr><td>Controls</td><td>Early blind</td><td>2 m/2 f</td><td>21.00 ± 2.94</td><td>88.75 ± 7.37</td><td>14.25 ± 1.71</td></tr><tr><td></td><td>Late blind</td><td>0 m/3 f</td><td>33.33 ± 9.71</td><td>89.33 ± 6.03</td><td>14.00 ± 5.29</td></tr><tr><td></td><td>Subgroup totals/means</td><td>2 m/5 f</td><td>26.29 ± 8.90</td><td>89.00 ± 6.27</td><td>14.14 ± 3.29</td></tr><tr><td>Totals/means</td><td></td><td>20 m/18 f</td><td>27.92 ± 8.51</td><td>82.72 ± 13.25</td><td>8.33 ± 8.24</td></tr></table> |
4101273cf350b59b81f6c4c9777f8b9567a268e9fdccb4d1ccecbfac58b61131.png | simple | <table><tr><td>Sensory neurons in the DRGs</td><td>BL40</td><td>GB30</td></tr><tr><td>Large-sized neuron</td><td>58 (10.78%)</td><td>149 (17.21%)</td></tr><tr><td>Medium-sized neuron</td><td>222 (41.26%)</td><td>357 (41.22%)</td></tr><tr><td>Small-sized neuron</td><td>258 (47.96%)</td><td>360 (41.57%)</td></tr></table> |
ffe1a52e30bc528287824da9c1e9034196659d9b7e62382eaefad754e44d0e31.png | complex | <table><tr><td></td><td></td><td>Number</td><td>Percent</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>379</td><td>90.9</td></tr><tr><td>Male</td><td>38</td><td>9.1</td></tr><tr><td rowspan="2">Country</td><td>Australia</td><td>396</td><td>94.9</td></tr><tr><td>New Zealand</td><td>21</td><td>5.1</td></tr><tr><td rowspan="5">Age (years)</td><td>21-30</td><td>23</td><td>5.5</td></tr><tr><td>31-40</td><td>84</td><td>20.1</td></tr><tr><td>41-50</td><td>156</td><td>37.4</td></tr><tr><td>51-60</td><td>141</td><td>33.8</td></tr><tr><td>60+</td><td>13</td><td>3.1</td></tr><tr><td rowspan="7">Length of Time Working in Haemodialysis</td><td><1 year</td><td>11</td><td>2.6</td></tr><tr><td>1-2 years</td><td>22</td><td>5.3</td></tr><tr><td>3-5 years</td><td>70</td><td>16.8</td></tr><tr><td>6-10 years</td><td>116</td><td>27.8</td></tr><tr><td>11-15 years</td><td>94</td><td>22.5</td></tr><tr><td>16-20 years</td><td>41</td><td>9.8</td></tr><tr><td>>20 years</td><td>63</td><td>15.1</td></tr><tr><td rowspan="2">Nursing Classification</td><td>Registered Nurse (RN)</td><td>406</td><td>97.4</td></tr><tr><td>Enrolled Nurse (EN)</td><td>11</td><td>2.6</td></tr><tr><td rowspan="5">Highest Nursing Qualification</td><td>Certificate in Nursing</td><td>85</td><td>20.4</td></tr><tr><td>Diploma in Nursing</td><td>56</td><td>13.4</td></tr><tr><td>Undergraduate Degree</td><td>74</td><td>17.7</td></tr><tr><td>Postgraduate Certificate/Diploma</td><td>170</td><td>40.8</td></tr><tr><td>Masters/Doctorate</td><td>32</td><td>7.7</td></tr><tr><td rowspan="4">Work Location</td><td>Metropolitan</td><td>177</td><td>42.4</td></tr><tr><td>Regional</td><td>144</td><td>34.5</td></tr><tr><td>Rural</td><td>85</td><td>20.4</td></tr><tr><td>Remote</td><td>11</td><td>2.6</td></tr><tr><td rowspan="3">Type of Unit</td><td>In-Center</td><td>187</td><td>44.8</td></tr><tr><td>Satellite</td><td>202</td><td>48.4</td></tr><tr><td>Home</td><td>28</td><td>6.7</td></tr></table> |
24bcffdcf4cfffb17ae99b3c57d6b8c21a1c0121a23ba048f8e6e5d02ee0a58f.png | simple | <table><tr><td>Inclusion criteria</td><td>Exclusion criteria</td></tr><tr><td>Women < 40 years old</td><td>Women who conceived the fetus using artificial methods including in-vitro fertilization or intrauterine insemination</td></tr><tr><td>Aboriginal ancestry</td><td>Women carrying more than one fetus</td></tr><tr><td>Pregnant with singleton</td><td>Surrogate mothers</td></tr><tr><td> </td><td>Women who suffer from severe chronic medical conditions including active cancer, severe infectious diseases including HIV, hepatitis B or C, or who are VDRL positive</td></tr></table> |
2e441c929de02b2c3166a45d220bd89e0c380af606344ffe2dd31974f5b2da7b.png | simple | <table><tr><td>Variable</td><td>Points</td></tr><tr><td>Age >80 years</td><td>1</td></tr><tr><td>History of cancer</td><td>1</td></tr><tr><td>History of heart failure or chronic lung disease</td><td>1</td></tr><tr><td>Pulse rate ≥110 bpm</td><td>1</td></tr><tr><td>Systolic blood pressure <100 mmHg</td><td>1</td></tr><tr><td>Oxygen saturation <90 % on room air</td><td>1</td></tr></table> |
45643286bbe872e3abf36a1d5e65435d2fee1d1aaf115ca863ee9a2378207c74.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Knowledgeable</td><td rowspan="2">COR 95 % CI</td><td rowspan="2">AOR 95 % CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>229</td><td>281</td><td>2.07 (1.55, 2.78)</td><td>1.89 (1.36, 2.61)**</td></tr><tr><td> Female</td><td>207</td><td>367</td><td>1</td><td>1</td></tr><tr><td colspan="5">Age (years)</td></tr><tr><td> 18–25</td><td>191</td><td>101</td><td>5.14 (3.18, 8.26)</td><td>2.42 (1.33, 4.40)*</td></tr><tr><td> 26–35</td><td>150</td><td>85</td><td>4.78 (2.92,7.80)</td><td>2.06 (1.13, 3.73)*</td></tr><tr><td> 36–45</td><td>64</td><td>66</td><td>2.63 (1.54, 4.49)</td><td>1.38 (0.75, 2.54)</td></tr><tr><td>> 45</td><td>31</td><td>84</td><td>1</td><td>1</td></tr><tr><td colspan="5">Educational status</td></tr><tr><td> Non formal education</td><td>18</td><td>84</td><td>1</td><td>1</td></tr><tr><td> Primary school (1–8<sup>th</sup>)</td><td>30</td><td>36</td><td>3.89 (1.93, 7.85)</td><td>2.93 (1.39, 6.17)*</td></tr><tr><td> Secondary (9–12<sup>th</sup>)</td><td>147</td><td>90</td><td>7.62 (4.30, 13.5)</td><td>3.33 (1.68, 6.60)**</td></tr><tr><td> Certificate & above</td><td>241</td><td>126</td><td>8.93 (5.14, 15.5)</td><td>4.39 (2.29, 8.39)**</td></tr><tr><td colspan="5">Source of information</td></tr><tr><td> Television</td><td>355</td><td>246</td><td>0.64 (0.38, 1.07)</td><td>1.03 (0.60, 1.76)</td></tr><tr><td> Radio</td><td>29</td><td>67</td><td>0.19 (0.10, 0.37)</td><td>0.37 (0.19, 0.75)*</td></tr><tr><td> Newspaper/Internet</td><td>52</td><td>23</td><td>1</td><td>1</td></tr></table> |
e8c7f458ee9bf0f5f4e0b76ab30972f906ba6b720a2fe6b01c49a3c50047de61.png | complex | <table><tr><td></td><td colspan="4">Geometric mean</td><td colspan="4">95th percentile</td></tr><tr><td></td><td colspan="2">DEP</td><td colspan="2">DEHP</td><td colspan="2">DEP</td><td colspan="2">DEHP</td></tr><tr><td>Population group</td><td>MEP</td><td>MEHP</td><td>MEHHP</td><td>MEOHP</td><td>MEP</td><td>MEHP</td><td>MEHHP</td><td>MEOHP</td></tr><tr><td>289 adults (Blount et al. 2000b)</td><td>345 (11.4)</td><td>3.0 (0.5)</td><td>ND</td><td>ND</td><td>2,610 (86.6)</td><td>15.2 (3.3)</td><td>ND</td><td>ND</td></tr><tr><td>2,536 persons 6 to > 20 years of age (Silva et al. 2004a)</td><td>163 (5.4)</td><td>3.12 (0.7)</td><td>ND</td><td>ND</td><td>1,950 (64.7)</td><td>18.5 (4.0)</td><td>ND</td><td>ND</td></tr><tr><td>2,772 persons 6 to > 20 years of age (CDC 2005)</td><td>167 (5.5)</td><td>3.99 (0.9)</td><td>18.8 (2.1)</td><td>12.6 (2.2)</td><td>1,860 (61.7)</td><td>32.8 (7.1)</td><td>147 (16.8)</td><td>87.5 (15.6)</td></tr><tr><td>85 children and adults (Koch et al. 2003c)a</td><td>165b (5.5)</td><td>12.4b (2.7)</td><td>57.2b (6.5)</td><td>41.7b (7.4)</td><td>673 (22.2)</td><td>34.7 (7.5)</td><td>143 (16.3)</td><td>106 (18.9)</td></tr></table> |
25bfb72d519b2b83aa58dd811a48e17270d8663a1917b1eb8804f2acce983ea7.png | simple | <table><tr><td></td><td>Description of framework objectives</td></tr><tr><td>1.</td><td>Surveillance to develop shared operational definitions and determinants of mental illness</td></tr><tr><td>2.</td><td>Epidemiological research into determinants and protective factors for mental health and their relationships to chronic diseases</td></tr><tr><td>3.</td><td>Prevention research to determine the importance of mental illness/health as factors in public health promotion and prevention</td></tr><tr><td>4.</td><td>Communication to develop culturally, linguistically, and developmentally appropriate educational products</td></tr><tr><td>5.</td><td>Education of Health Professionals including the development of appropriate education plans for professional audiences</td></tr><tr><td>6.</td><td>Program Integration Support at various jurisdictional levels</td></tr><tr><td>7.</td><td>Policy Integration that involves the development of policies at all government levels for all audiences and stakeholders</td></tr><tr><td>8.</td><td>Systems to Promote Integration such as establish systems integration to promote program and policy integration across multiple infrastructures</td></tr></table> |
710880b3018f5eb8f539acede6eff451f5f0cd3dfcbb824ec488293e9ad43eb4.png | simple | <table><tr><td>Parameter<sup>†</sup></td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Standard deviation</td></tr><tr><td>TK</td><td>6 </td><td>73 </td><td>47.47 </td><td>12.7</td></tr><tr><td>LL </td><td>2 </td><td>67 </td><td>39.62 </td><td>12.4 </td></tr><tr><td>TT </td><td>0 </td><td>21 </td><td>7.08 </td><td>4.9 </td></tr><tr><td>LT </td><td>0 </td><td>24 </td><td>12.09 </td><td>5.9 </td></tr><tr><td>PT </td><td>0 </td><td>27 </td><td>10.32 </td><td>6.5 </td></tr><tr><td>PI </td><td>4 </td><td>70 </td><td>45.37 </td><td>10.7 </td></tr><tr><td>SS </td><td>13 </td><td>55 </td><td>35.37 </td><td>8.1 </td></tr></table> |
e55ab5e747102986feae08b404bd5c01b918db1bf8acf7c2635573b1ff20f0b8.png | complex | <table><tr><td rowspan="2">Outcome</td><td colspan="2">Regression coefficient(95%CI)</td></tr><tr><td>Publication year</td><td>Type of fractures</td></tr><tr><td>Blood loss</td><td>− 0.02 (− 0.11, 0.08)</td><td>− 0.70 (− 2.04, 0.64)</td></tr><tr><td>Operation time</td><td>− 0.32 (− 0.10, 0.04)</td><td>− 0.22 (− 1.28, 0.83)</td></tr></table> |
74af3182eb6791dec6b10d183cbe23cf937d4fed293d0a118346eec0f70d1d31.png | simple | <table><tr><td>Scale</td><td>Fatigue description</td></tr><tr><td>1</td><td>No such feeling</td></tr><tr><td>2</td><td>Negligible feeling</td></tr><tr><td>3</td><td>Some feeling</td></tr><tr><td>4</td><td>Clear feeling</td></tr><tr><td>5</td><td>Strong feeling</td></tr><tr><td>6</td><td>Very strong feeling</td></tr><tr><td>7</td><td>Extremely strong feeling</td></tr></table> |
44ffb94e5db4d3242ef864e9425cb0d0435eb55be3be34651ace3a99498359ac.png | complex | <table><tr><td colspan="2">C/N<sub>0</sub></td><td>25 dB-Hz</td><td>30 dB-Hz</td><td>35 dB-Hz</td><td>40 dB-Hz</td></tr><tr><td rowspan="3">Standard Receiver</td><td>Optimal Bandwidth</td><td>15 Hz</td><td>22 Hz</td><td>28 Hz</td><td>35 Hz</td></tr><tr><td>Tracking Error of the PLL in Optimal Bandwidth</td><td>28 deg.</td><td>15 deg.</td><td>9 deg.</td><td>7 deg.</td></tr><tr><td>Dynamic Stress Noise Proportion (B<sub>PLL</sub> = 20 Hz)</td><td>8%</td><td>14%</td><td>21%</td><td>28%</td></tr><tr><td rowspan="3">Ultra-tightly Integrated GNSS/INS Receiver</td><td>Optimal Bandwidth</td><td>7 Hz</td><td>9 Hz</td><td>13 Hz</td><td>25 Hz</td></tr><tr><td>Tracking Error of the PLL in Optimal Bandwidth</td><td>20 deg.</td><td>12 deg.</td><td>8 deg.</td><td>6 deg.</td></tr><tr><td>Dynamic Stress Noise Proportion (B<sub>PLL</sub> = 20 Hz)</td><td><1%</td><td><1%</td><td><1%</td><td><1%</td></tr></table> |
be68ba610c313773d33d603ec262428096bf420d41a44b7651fb252ff8430b22.png | complex | <table><tr><td>Variable</td><td colspan="2">Time to report to hospital</td><td rowspan="2">P-value</td><td> </td><td> </td></tr><tr><td> </td><td>Less than one week</td><td>One week and above</td><td>COR*(95 %CI#)</td><td>AOR**(95% CI)</td></tr><tr><td>Age of the child</td><td> </td><td> </td><td> </td><td> </td><td rowspan="4"> </td></tr><tr><td>- Less than 5 years</td><td>28(17.2)</td><td>10(9.6)</td><td>0.062</td><td>0.47(0.21-1.04)</td></tr><tr><td>- Five to ten years</td><td>62(38.0)</td><td>38(36.5)</td><td>0.409</td><td>0.80(0.47-1.36)</td></tr><tr><td>- More than 10 years</td><td>73(44.8)</td><td>56(53.8)</td><td>1</td><td>1</td></tr><tr><td>Sex of the child</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>- Male</td><td>28(17.2)</td><td>37(35.6)</td><td>0.001</td><td>2.66(1.50-4.70)</td><td>2.40(1.34-4.31)</td></tr><tr><td>- Female</td><td>135(82.8)</td><td>67(64.4)</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Previous history of abuse</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>- Yes</td><td>20(12.3)</td><td>25(24.0)</td><td>0.010</td><td>2.26(1.18-4.33)</td><td>1.88(0.96-3.68)</td></tr><tr><td>- No</td><td>143(87.7)</td><td>79(76.0)</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Place of residence</td><td> </td><td> </td><td> </td><td> </td><td rowspan="3"> </td></tr><tr><td>- Addis Ababa</td><td>140(85.9)</td><td>89(85.6)</td><td>0.539</td><td>0.89(0.48-2.93)</td></tr><tr><td>- Out of Addis Ababa</td><td>23(14.1)</td><td>15(14.4)</td><td>1</td><td>1</td></tr><tr><td>Is the abuser known to the child?</td><td> </td><td> </td><td> </td><td> </td><td rowspan="3"> </td></tr><tr><td>- Yes</td><td>113(69.3)</td><td>82(78.8)</td><td>0.057</td><td>1.64(0.92-2.93)</td></tr><tr><td>- No</td><td>50(30.7)</td><td>22(21.2)</td><td>1</td><td>1</td></tr></table> |
5b57e557412b6f65e642808355b649099129f582d30d27e504e9942fa0661d92.png | complex | <table><tr><td></td><td colspan="2">2006</td><td colspan="2">2007</td><td colspan="2">2008</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>United States</td><td>1,025</td><td></td><td>1,021</td><td></td><td>658</td><td></td></tr><tr><td> Any SSM</td><td></td><td>24.4</td><td></td><td>33.0</td><td></td><td>48.8 1</td></tr><tr><td> NRT</td><td></td><td>19.5</td><td></td><td>16.5</td><td></td><td>22.2</td></tr><tr><td> Bupropion</td><td></td><td>4.8</td><td></td><td>3.4</td><td></td><td>4.3</td></tr><tr><td> Varenicline</td><td></td><td>0.4</td><td></td><td>13.7</td><td></td><td>21.7 1</td></tr><tr><td>United Kingdom</td><td>903</td><td></td><td>843</td><td></td><td>704</td><td></td></tr><tr><td> Any SSM</td><td></td><td>31.9</td><td></td><td>36.3</td><td></td><td>36.6 1</td></tr><tr><td> NRT</td><td></td><td>29.8</td><td></td><td>32.7</td><td></td><td>29.1</td></tr><tr><td> Bupropion</td><td></td><td>1.9</td><td></td><td>1.1</td><td></td><td>2.0</td></tr><tr><td> Varenicline</td><td></td><td>0.0</td><td></td><td>2.0</td><td></td><td>4.41</td></tr><tr><td>Canada</td><td>975</td><td></td><td>927</td><td></td><td>676</td><td></td></tr><tr><td> Any SSM</td><td></td><td>31.1</td><td></td><td>32.3</td><td></td><td>45.7 1</td></tr><tr><td> NRT</td><td></td><td>26.8</td><td></td><td>24.1</td><td></td><td>24.6</td></tr><tr><td> Bupropion</td><td></td><td>4.8</td><td></td><td>5.5</td><td></td><td>5.5</td></tr><tr><td> Varenicline</td><td></td><td>0.0</td><td></td><td>2.3</td><td></td><td>14.8 1</td></tr><tr><td>Australia</td><td>1,119</td><td></td><td>999</td><td></td><td>697</td><td></td></tr><tr><td> Any SSM</td><td></td><td>31.5</td><td></td><td>35.3</td><td></td><td>45.6 1</td></tr><tr><td> NRT</td><td></td><td>26.0</td><td></td><td>29.8</td><td></td><td>24.5</td></tr><tr><td> Bupropion</td><td></td><td>5.2</td><td></td><td>5.1</td><td></td><td>5.6</td></tr><tr><td> Varenicline</td><td></td><td>0.0</td><td></td><td>0.12</td><td></td><td>14.5 1</td></tr></table> |
77fcd9e307b5ffad987a1d9a049aa0ea0ba3d81315cbe855d8d043901949add7.png | complex | <table><tr><td>Characteristic</td><td>Number (%)</td></tr><tr><td>Male (n = 412)</td><td>220 (53)</td></tr><tr><td colspan="2">Role in ED (n = 419)</td></tr><tr><td> Attending</td><td>207 (49)</td></tr><tr><td> Resident</td><td>170 (41)</td></tr><tr><td> Advanced practice provider</td><td>42 (10)</td></tr><tr><td colspan="2">Years working in ED (n = 417)</td></tr><tr><td> < 1 year</td><td>52 (13)</td></tr><tr><td> > 1 – < 5 years</td><td>164 (39)</td></tr><tr><td> > 5 – < 10 years</td><td>53 (13)</td></tr><tr><td> > 10 – < 20 years</td><td>85 (20)</td></tr><tr><td> > 20 years</td><td>63 (15)</td></tr><tr><td colspan="2">Location of ED* (n = 420)</td></tr><tr><td> Rural</td><td>8 (2)</td></tr><tr><td> Suburban</td><td>24 (6)</td></tr><tr><td> Urban</td><td>410 (98)</td></tr><tr><td colspan="2">ED practice setting* (n = 420)</td></tr><tr><td> Academic</td><td>409 (97)</td></tr><tr><td> Community</td><td>71 (17)</td></tr><tr><td> VA/military</td><td>16 (4)</td></tr><tr><td>Prior therapeutic OA use (n=420)</td><td>265 (63)</td></tr></table> |
9a83015468ca5992f747fd373c45a9f5d42457740b61068e902867376ced850d.png | simple | <table><tr><td>Tissue</td><td>Content of poncirin (mg/g FW)</td></tr><tr><td>flavedo</td><td>0.15 ± 0.01</td></tr><tr><td>albedo</td><td>1.37 ± 0.09</td></tr><tr><td>segment membrane</td><td>0.52 ± 0.01</td></tr><tr><td>juice sac</td><td>0.07 ± 0.01</td></tr></table> |
f7d1582fc0a87d823d6f3e0f27a642fa636c49d895f924068386356b444fe51f.png | simple | <table><tr><td>Problem</td><td>Possible Reason</td><td>Solution</td></tr><tr><td>Genome is not fragmented after sonication.</td><td>Buffer condition is not adaptable for sonication.</td><td>Purify the DNA. We used QIAGEN PCR Purification Kit, eluted in EB to have it work.</td></tr><tr><td>Nothing is visible on the gel after 1 hr electrophoresis during library generation.</td><td>When the starting amount of DNA is small or there is significant DNA loss during the process for various reasons, it is possible that the DNA is smeared over a wide range after an hour of electrophoresis and not visible on the gel.</td><td>It is good to check the gel to see if the DNA is present after ~10 min run when the DNA is not smeared at a wide range.Even though nothing is visible, it is highly possible that the DNA is still present. Proceed to the next step regardless and see if PCR amplifies anything.</td></tr><tr><td>Cannot collect ~400 ul after the stripping step.</td><td>Gasket slide was re-used.The array slide was lifted up too quickly.Different buffer was used for the 95C stripping process.</td><td>Do not re-use the gasket slide.The solution can be flushed to a collection boat and collected.When using multi-array slides like 2×105 K, 4×44 K or 8×15 K, it is still possible to run the capture protocol as indicated. After the stripping, the array slide should be slowly lifted up to prevent contamination. The solution tends to stay within the gaskets.</td></tr><tr><td>Not enough DNA amplified after the first stripping.</td><td>Stripping was not efficient.</td><td>Another stripping process can be done and checked if there were left over genomic fragments hybridized on the probes. Since it does not matter if the stripped solution contains contaminants as long as the contaminants do not have adapters ligated at the end, it is possible to thoroughly continue the stripping process until no products get amplified.</td></tr></table> |
b49432c62a1156818cbb2db54b6bf68e08b5f530660370c911da5856483c6f24.png | complex | <table><tr><td rowspan="2">Dietary Intake Adequacy Based on Mean Adequacy Ratio (MAR)</td><td>Minimum Dietary Diversity</td><td>Minimum Meal Frequency</td><td>Minimum Acceptable Diet</td><td>Consumption of Iron-Rich/Fortified Food</td></tr><tr><td colspan="4">Odds Ratio (95% CI)</td></tr><tr><td><sup>b</sup> MAR > 0.6 (more than 60.0%)</td><td>11.10 (3.09, 39.87), <i>p</i> = 0.000</td><td>6.70 (1.44, 31.16), <i>p</i> = 0.015</td><td>4.03 (1.17, 13.87), <i>p</i> = 0.027</td><td>2.73 (0.45, 16.48), <i>p</i> = 0.273</td></tr><tr><td>0.5 < <sup>a</sup> MAR ≤ 0.6 (50.1%–60.0%)</td><td>5.49 (1.35, 22.22), <i>p</i> = 0.017</td><td>1.60 (0.35, 7.30), <i>p</i> = 0.544</td><td>2.96 (0.75, 11.67), <i>p</i> = 0.121</td><td>1.33 (0.20, 9.00), <i>p</i> = 0.768</td></tr></table> |
a8d17825c60a3a55c9b188d675d92df4e650a9542cfd1ed69d9bab8114bf1305.png | complex | <table><tr><td rowspan="2">ScheduleTreatment day (TD)Time point (T)</td><td rowspan="2">T0 (Screening, baseline and prediagnosis tests)</td><td colspan="7">T1 (Treatment and discharge)</td><td rowspan="2">T2 3M</td><td rowspan="2">T3 6M</td><td rowspan="2">T4 12M</td><td rowspan="2">Withdrawal</td></tr><tr><td>TD 1*</td><td>TD 2</td><td>TD 3</td><td>TD 4</td><td>TD 5</td><td>Rescue therapy†</td><td>Discharge</td></tr><tr><td>Screening with diagnostic algorithm and core investigations including physical examination</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Patient information and informed consent</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Eligibility form</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Registration form</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Prediagnosis tests—for example, MRI and AQP4</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Randomisation</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Biobank samples</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td></tr><tr><td>ASIA Impairment Score (A-E)</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>P</td><td>X</td><td></td></tr><tr><td>ASIA Motor and Sensory Score</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>Neurostatus scoring (Kurtzke functional systems and EDSS)</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>8–12 years EQ-5D-Y</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>≥13 years EQ-5D-5L</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>≥13 years SCI QoL Basic data set</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>CSRI</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>S</td><td>X</td><td></td></tr><tr><td>≥13 years SCI Bladder</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>T</td><td>X</td><td></td></tr><tr><td>≥13 years SCI Bowel</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>T</td><td>X</td><td></td></tr><tr><td>5–7 years Peds QL</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>T</td><td>X</td><td></td></tr><tr><td>2–4 years Peds QL</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>T</td><td>X</td><td></td></tr><tr><td>Treatment form</td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Concomitant medications</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td></td></tr><tr><td>Discharge form</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Rescue therapy form (if needed)†</td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Relapse form (at any time point if needed)†</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td></td></tr><tr><td>Adverse events‡</td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Study Status Form</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td></td></tr><tr><td>Withdrawal form (at any time point)†</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td></tr></table> |
ec6bd9e6f6814f3db264a58330e15179f9d95ff292c577fcfd6902c79251770b.png | simple | <table><tr><td>Study</td><td>Number of patients</td><td>Follow-up (days)</td><td>Baseline comparison</td><td>Adverse event</td><td>Outcomes measure (primary/secondary)</td><td>Treatment group dosage</td><td>Types of stroke</td></tr><tr><td>Cai et al. 2000 [29]</td><td>256</td><td>14</td><td>Y</td><td>N</td><td>TER, CSS</td><td>XNJ 30–60 mL/d + CWM</td><td>IS</td></tr><tr><td>Chen et al. 2004a [30]</td><td>100</td><td>14</td><td>Y</td><td>N</td><td>TER</td><td>XNJ 20 mL/d + CWM</td><td>IS</td></tr><tr><td>Chen et al. 2004b [31]</td><td>70</td><td>14</td><td>Y</td><td>N</td><td>TNF-<i>α</i>, IL-6, IL-1, ESSS</td><td>XNJ 40 mL/d + CWM</td><td>ICH</td></tr><tr><td>Chen 2013 [32]</td><td>202</td><td>21</td><td>Y</td><td>Y</td><td>NIHSS, IL-9</td><td>XNJ 30 mL/d + CWM</td><td>ICH</td></tr><tr><td>Lei 2013 [33]</td><td>120</td><td>28</td><td>Y</td><td>Y</td><td>TER</td><td>XNJ 20 mL/d + CWM</td><td>ICH</td></tr><tr><td>Li 2011 [34]</td><td>118</td><td>14</td><td>Y</td><td>N</td><td>TNF-<i>α</i>, IL-6, NIHSS</td><td>XNJ 40 mL/d + CWM</td><td>ICH</td></tr><tr><td>Liu and Bai 2004 [35]</td><td>70</td><td>14</td><td>Y</td><td>N</td><td>TNF-<i>α</i>, IL-6, IL-8, ESSS</td><td>XNJ 40 mL/d + CWM</td><td>ICH/IS</td></tr><tr><td>Ming et al. 2010 [36]</td><td>91</td><td>21</td><td>Y</td><td>N</td><td>ESS,</td><td>XNJ 20 mL/d + CWM</td><td>ICH</td></tr><tr><td>Wang 2013 [37]</td><td>155</td><td>14</td><td>Y</td><td>N</td><td>TER</td><td>XNJ 20 mL/d + CWM</td><td>ICH/IS/SAH</td></tr><tr><td>Wei and Li 2009 [13]</td><td>120</td><td>28</td><td>Y</td><td>Y</td><td>TER, CSS</td><td>XNJ 10 mL/d + CWM</td><td>ICH</td></tr><tr><td>Zhang et al. 2012 [38]</td><td>65</td><td>14</td><td>Y</td><td>N</td><td>NIHSS</td><td>XNJ 20 mL/d + CWM</td><td>IS</td></tr><tr><td>Zhang et al. 2013 [39]</td><td>63</td><td>14</td><td>Y</td><td>N</td><td>NIHSS</td><td>XNJ 20 mL/d + CWM</td><td>IS</td></tr><tr><td>Zhou et al. 2005 [40]</td><td>84</td><td>28</td><td>Y</td><td>N</td><td>TER</td><td>XNJ 20 mL/d + CWM</td><td>ICH</td></tr></table> |
286b103c369fad5f7b929cf626e533fdb6b0624993c241dd6965797156685fce.png | simple | <table><tr><td></td><td>No Bone Graft(n = 18)</td><td>Bone Graft(n = 29)</td><td><i>p value</i></td></tr><tr><td>Pain severity, neck</td><td>10.37</td><td>17.01</td><td><i>0.139</i></td></tr><tr><td>Pain severity, arm</td><td>7.22</td><td>6.44</td><td><i>0.628</i></td></tr><tr><td>Functional disability</td><td>18.78</td><td>21.01</td><td><i>0.877</i></td></tr><tr><td>Psychological distress</td><td>19.14</td><td>38.37</td><td><i>0.024</i></td></tr><tr><td>Physical symptoms other than neck/arm pain</td><td>12.96</td><td>18.07</td><td><i>0.344</i></td></tr><tr><td>Healthcare utilisation</td><td>24.44</td><td>22.07</td><td><i>0.415</i></td></tr></table> |
886197977c4b95eec5eed00a58a172779a219447212d99343d0725119d13dfd2.png | simple | <table><tr><td></td><td>CA-AKI and RIFLE (<i>n</i> = 14)</td><td>CA-AKI (<i>n</i> = 9)</td><td>Only RIFLE (<i>n</i> = 31)</td><td>No CA-AKI (<i>n</i> = 95)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>73 [61–80]</td><td>60 [48–67]</td><td>68 [57–75]</td><td>63 [55–71]</td><td>0.08</td></tr><tr><td>Sex (male/female)</td><td>10/4</td><td>6/3</td><td>22/9</td><td>55/40</td><td>0.55</td></tr><tr><td>ICU admission diagnosis (medical/surgical)</td><td>11/3*</td><td>7/2</td><td>29/2*</td><td>77/18</td><td>0.41</td></tr><tr><td>APACHE II score</td><td>26 [20–30]*</td><td>21 [17–28]</td><td>18 [11–26]</td><td>20 [14–23]</td><td>0.04</td></tr><tr><td>Weight (kg)</td><td>80 [74–90]</td><td>72 [60–88]</td><td>84 [75–95]*</td><td>75 [65–86]</td><td>0.05</td></tr><tr><td>Diabetes mellitus (%)</td><td>4 (29)</td><td>2 (22)</td><td>9 (29)</td><td>26 (27)</td><td>0.98</td></tr><tr><td>Nephrotoxic drugs</td><td>5 (36)</td><td>4 (44)</td><td>14 (45)</td><td>43 (45)</td><td>0.92</td></tr><tr><td>Cardiovascular risk factors (%)</td><td>11 (79)</td><td>6 (75)</td><td>23 (74)</td><td>65 (68)</td><td>0.86</td></tr><tr><td>Need for renal replacement (%)</td><td>3 (21)*</td><td>0 (0)</td><td>3 (10)*</td><td>0 (0)</td><td><0.001</td></tr><tr><td>Length of ICU stay (days)</td><td>15 [12–18]</td><td>10 [6–19]</td><td>8 [5–21]</td><td>12 [8–23]</td><td>0.42</td></tr><tr><td>ICU mortality (%)</td><td>9 (64)*</td><td>3 (33)</td><td>9 (29)</td><td>14 (15)</td><td><0.001</td></tr><tr><td>Haematocrit (%)</td><td>32 .2 [29.2–40.2]</td><td>28.5 [24.8–33.0]</td><td>32.1 [26.9–40.8]</td><td>30.6 [27.1–36.6]</td><td>0.37</td></tr><tr><td>Urea (mg/dL)</td><td>50 [42–57]</td><td>40 [31–54]</td><td>40 [32–60]</td><td>44 [32–58]</td><td>0.57</td></tr><tr><td>Creatinine (mg/dL)</td><td>1.18 [1.00–1.40]*</td><td>0.80 [0.45–1.10]</td><td>0.98 [0.74–1.18]</td><td>0.84 [0.62–1.08]</td><td>0.03</td></tr><tr><td>MDRD mL/min/1.73 m2</td><td>52 [46–71]</td><td>80 [66–173]</td><td>76 [52–92]</td><td>82 [59–128]</td><td>0.06</td></tr><tr><td>Patients with creatinine ≥1.5 mg/dL</td><td>1 (9 %)</td><td>1 (14 %)</td><td>4 (12.9 %)</td><td>9 (9.5 %)</td><td>0.93</td></tr><tr><td>pH</td><td>7.37 [7.30–7.42]</td><td>7.42 [7.27–7.48]</td><td>7.36 [7.30–7.42]</td><td>7.42 [7.33–7.46]</td><td>0.08</td></tr><tr><td>BE (meq/L)</td><td>−2 [−6–2]</td><td>1 [−3–7]</td><td>−1 [−4–0]</td><td>1 [−2–5]</td><td>0.08</td></tr><tr><td>HCO3 (mmoL/L)</td><td>22.9 [20.7–25.2]</td><td>25.0 [23.5–31.4]</td><td>24.0 [21.4–27.8]</td><td>25.7 [22.0–30.3]</td><td>0.29</td></tr><tr><td>Na (mEq/L)</td><td>140 [136–142]</td><td>138 [134–140]</td><td>139 [137–143]</td><td>140 [137–143]</td><td>0.19</td></tr><tr><td>CPK (UI/mL)</td><td>171 [91–854]</td><td>203 [11–376]</td><td>199 [49–604]</td><td>117 [44–348]</td><td>0.32</td></tr><tr><td>CRP (mg/dL)</td><td>15.6 [6.6–22.8]</td><td>8.7 [3.6–17.3]</td><td>7.4 [0.5–13.0]</td><td>9.3 [2.5–18.4]</td><td>0.13</td></tr><tr><td>Lactate (mmol/L)</td><td>1.0 [0.6–1.3]</td><td>0.6 [0.5–0.9]</td><td>0.4 [0.4–0.8]</td><td>0.5 [0.5–0.7]</td><td>0.11</td></tr><tr><td>Nephropathy prevention (%)</td><td>2 (14.2)</td><td>0 (0)</td><td>6 (19.4)</td><td>21 (22)</td><td>0.41</td></tr><tr><td>Mean blood pressure before CM (mmHg)</td><td>80 [64–94]</td><td>70 [62–87]</td><td>84 [74–91]</td><td>81 [71–94]</td><td>0.51</td></tr><tr><td>Mean blood pressure at 6 h (mmHg)</td><td>72 [66–88]</td><td>72 [60–79]</td><td>77 [68–88]</td><td>81 [71–96]</td><td>0.10</td></tr><tr><td>Mean blood pressure at 12 h (mmHg)</td><td>73 [64–74]*</td><td>74 [68–80]</td><td>74 [69–79]</td><td>79 [70–88]</td><td>0.02</td></tr><tr><td>Mean blood pressure at day 1 (mmHg)</td><td>71 [65–74]*</td><td>76 [69–80]</td><td>74 [68–83]</td><td>85 [74–97]</td><td><0.001</td></tr><tr><td>Mean blood pressure at day 2 (mmHg)</td><td>67 [64–77]*</td><td>74 [68–77]*</td><td>79 [71–86]*</td><td>90 [79–98]</td><td><0.001</td></tr><tr><td>Mean blood pressure at day 3 (mmHg)</td><td>76 [69–88]*</td><td>71 [65–85]*</td><td>77 [69–88]*</td><td>88 [77–100]</td><td><0.001</td></tr><tr><td>CVP before CM (mmHg)</td><td>10 [6–14]</td><td>13 (11–14]</td><td>10 [8–11]</td><td>9 [5–11]</td><td>0.14</td></tr><tr><td>Maximal vasopressor dose on the day of CM (mcg/kg/min)</td><td>0.12 [0.00–0.20]* vs no</td><td>0.00 [0.00–0.15]</td><td>0.04 [0.00–0.12]</td><td>0.00 [0.00–0.00]</td><td>0.004</td></tr><tr><td>Maximal vasopressor dose, day 1 (mcg/kg/min)</td><td>0.10 [0.05–0.40]*</td><td>0.00 [0.00–0.06]</td><td>0.00 [0.00–0.06]</td><td>0.00 [0.00–0.00]</td><td><0.001</td></tr><tr><td>Maximal vasopressor dose, day 2 (mcg/kg/min)</td><td>0.19 [0.00–0.40]*</td><td>0.00 [0.00–0.04]</td><td>0.00 [0.00–0.08]</td><td>0.00 [0.00–0.00]</td><td><0.001</td></tr><tr><td>Maximal vasopressor dose, day 3 (mcg/kg/min)</td><td>0.15 [0.00–0.30]*</td><td>0.00 [0.00–0.09]</td><td>0.00 [0.00–0.01]</td><td>0.00 [0.00–0.00]</td><td><0.001</td></tr><tr><td>Doses of CM (ml/kg)</td><td>1.54 [1.47–5.38]</td><td>1.64 [1.33–1.85]</td><td>1.53 [1.17–1.61]</td><td>1.60 [1.21–1.85]</td><td>0.32</td></tr><tr><td>Diuretics on day of CM injection (%)</td><td>1 (9 %)</td><td>5 (71 %)*</td><td>3 (12 %)</td><td>7 (13 %)</td><td><0.001</td></tr><tr><td>Fluid intake, day 0 (ml)</td><td>3015 [2200–3885]</td><td>2495 [1774–3030]</td><td>2600 [2058–3516]</td><td>2830 [2124–3814]</td><td>0.65</td></tr><tr><td>Fluid intake, day 1 (ml)</td><td>3371 [2125–4184]</td><td>3371 [2125–4184]</td><td>3085 [2005–3748]</td><td>2865 [2098–3676]</td><td>0.49</td></tr><tr><td>Fluid intake, day 2 (ml)</td><td>3069 [1786–3780]</td><td>2090 [1730–3369]</td><td>2810 [2186–3124]</td><td>2550 [1949–3395]</td><td>0.78</td></tr><tr><td>Fluid intake, day 3 (ml)</td><td>2640 [1738–3811]</td><td>2750 [1820–3308]</td><td>2285 [1628–3103]</td><td>2465 [1690–3360]</td><td>0.63</td></tr></table> |
641ab38659c6f8338db003df48679d42c394386440b9bf6ddaa594e0492bb4a1.png | simple | <table><tr><td>Step</td><td>(min) Time</td><td>(W) Power</td><td>Temp. (°C)</td></tr><tr><td>1</td><td>15</td><td>450</td><td>195</td></tr><tr><td>2</td><td>2.0</td><td>0</td><td>190</td></tr><tr><td>3</td><td>10</td><td>300</td><td>195</td></tr><tr><td>4</td><td>15</td><td>350</td><td>195</td></tr></table> |
230054d5393c4df43005d72ca8f7c4e357a7addd20329572ec649947ea439994.png | simple | <table><tr><td>Locality</td><td>Taxon</td><td>Site</td><td>Latitude</td><td>Longitude</td><td>Depth (m)</td><td>No. of tube fragments*</td></tr><tr><td>Antarctic</td><td><i>Sclerolinum</i> sp.</td><td>Hook Ridge Site 1</td><td>−62.1969</td><td>−57.2975</td><td>1174</td><td>686*</td></tr><tr><td></td><td></td><td>Hook Ridge Site 2</td><td>−62.1924</td><td>−57.2783</td><td>1054</td><td>87*</td></tr><tr><td></td><td></td><td>Kemp Caldera</td><td>−59.6948</td><td>−28.35</td><td>1432</td><td>95*</td></tr><tr><td>Arctic</td><td><i>S. contortum</i></td><td>Loki’s Castle CG2009</td><td>73.5662</td><td>8.1585</td><td>2357</td><td>33*</td></tr><tr><td></td><td></td><td>Loki’s Castle CG2008</td><td>73.5662–73.5683</td><td>8.1585–8.1563</td><td>-</td><td>8*</td></tr><tr><td></td><td></td><td>HMMV CG2010</td><td>71.9975–71.9999</td><td>14.7329–14.7316</td><td>1262</td><td>1*</td></tr><tr><td></td><td></td><td>HMMV VICKING 2006</td><td>72.0013</td><td>14.7225</td><td>1270</td><td>50+</td></tr><tr><td>GoM</td><td><i>S. contortum</i></td><td>Walker Ridge WR269</td><td>26.6833</td><td>−91.65</td><td>1954</td><td>21*</td></tr></table> |
ae75da9e746c5b6fcffb01f39bb20ed1c7279df2b85b5d6263aef0eadde38079.png | complex | <table><tr><td rowspan="2">Data source</td><td colspan="3"># of annotated exons</td><td colspan="3"># of mapped exon</td></tr><tr><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq -rheMac3</td><td>Ensembl-rheMac2</td><td>GASS</td><td>RefSeq-rheMac3</td></tr><tr><td>SRR299127</td><td rowspan="3">122,454</td><td rowspan="3">146,364</td><td rowspan="3">45,540</td><td>16,696(13.63%)</td><td>24,001 (16.40%)</td><td>9,341(20.51%)</td></tr><tr><td>SRR832953</td><td>108,940(88.96%)</td><td>131,393(89.77%)</td><td>43,398(95.29%)</td></tr><tr><td>SRR594464</td><td>94,115(76.85%)</td><td>102,831(70.25%)</td><td>40.291(88.47%)</td></tr></table> |
822e3d2ea9e6adf2b2cc75ba89b9eca367d691f8d8fbeef130850daa0011279e.png | complex | <table><tr><td rowspan="2">ID</td><td rowspan="2">Gender</td><td rowspan="2">Age</td><td rowspan="2">TNM</td><td rowspan="2">Tumor sublocation</td><td rowspan="2">Chemotherapy</td><td colspan="3">Volume (cm<sup>3</sup>)</td><td colspan="2">Mean planned PG dose (Gy)</td><td colspan="2">Xerostomia NTCP (%) [23, 24]</td></tr><tr><td>CTV70</td><td>ILP</td><td>CLP</td><td>ILP</td><td>CLP</td><td>ILP</td><td>CLP</td></tr><tr><td>1</td><td>M</td><td>77</td><td>T4N0</td><td>Tonsil</td><td>Cetuximab</td><td>45.2</td><td>52.1</td><td>48.6</td><td>30.2</td><td>31.1</td><td>27.1</td><td>28.9</td></tr><tr><td>2</td><td>F</td><td>61</td><td>T2N2</td><td>Base of tongue</td><td>CDDP</td><td>26.3</td><td>31.1</td><td>27.5</td><td>31.4</td><td>26</td><td>29.7</td><td>19.1</td></tr><tr><td>3</td><td>M</td><td>70</td><td>T3N2c</td><td>Oropharynx</td><td>CDDP</td><td>181.5</td><td>24.9</td><td>20.7</td><td>37.9</td><td>31.1</td><td>45.1</td><td>29.1</td></tr><tr><td>4</td><td>F</td><td>66</td><td>T2N2c</td><td>Oropharynx</td><td>Cetuximab</td><td>107.2</td><td>27.8</td><td>23.4</td><td>32.9</td><td>27.9</td><td>33.1</td><td>22.5</td></tr><tr><td>5</td><td>M</td><td>57</td><td>T3N0</td><td>Velum</td><td>CDDP</td><td>62.4</td><td>20.7</td><td>18</td><td>28.1</td><td>27.8</td><td>23</td><td>22.3</td></tr><tr><td>6</td><td>M</td><td>67</td><td>T3N2c</td><td>Base of tongue</td><td>CDDP</td><td>156.2</td><td>24.5</td><td>22.7</td><td>30.8</td><td>29.4</td><td>25.4</td><td>22.1</td></tr><tr><td>7</td><td>M</td><td>52</td><td>T4N2a</td><td>Tonsil</td><td>Cetuximab</td><td>165.1</td><td>N/A</td><td>21.6</td><td>N/A</td><td>28.7</td><td>N/A</td><td>24</td></tr><tr><td>8</td><td>M</td><td>67</td><td>T4N1</td><td>Base of tongue</td><td>CDDP</td><td>139.3</td><td>22</td><td>19.3</td><td>30.7</td><td>29.2</td><td>28</td><td>25</td></tr><tr><td>9</td><td>F</td><td>65</td><td>T3N3</td><td>Base of tongue</td><td>CDDP</td><td>237.5</td><td>23.9</td><td>20.2</td><td>42.4</td><td>31.1</td><td>56.1</td><td>29</td></tr><tr><td>10</td><td>F</td><td>65</td><td>T4N3</td><td>Oropharynx</td><td>CDDP</td><td>257.9</td><td>N/A</td><td>24.5</td><td>N/A</td><td>35.2</td><td>N/A</td><td>38.5</td></tr><tr><td>11</td><td>M</td><td>50</td><td>T4N2c</td><td>Oropharynx</td><td>CDDP</td><td>434.5</td><td>N/A</td><td>17.7</td><td>N/A</td><td>36.3</td><td>N/A</td><td>41.1</td></tr><tr><td>12</td><td>M</td><td>53</td><td>T3N0</td><td>Base of tongue</td><td>CDDP</td><td>14.4</td><td>16.6</td><td>23.3</td><td>41.3</td><td>24.2</td><td>53.6</td><td>16.3</td></tr><tr><td>13</td><td>M</td><td>73</td><td>T3N2c</td><td>Oropharynx</td><td>Cetuximab</td><td>147</td><td>29.4</td><td>29.2</td><td>54.6</td><td>32.2</td><td>82.1</td><td>31.4</td></tr><tr><td>14</td><td>M</td><td>56</td><td>T3N0</td><td>Epiglottic</td><td>Cetuximab</td><td>14</td><td>22.8</td><td>29.2</td><td>19.7</td><td>9.2</td><td>10.3</td><td>2.7</td></tr><tr><td>15</td><td>M</td><td>75</td><td>T2N2a</td><td>Oropharynx</td><td>Cetuximab</td><td>76.3</td><td>20.3</td><td>22.4</td><td>29.4</td><td>29.1</td><td>25.6</td><td>25</td></tr><tr><td>16</td><td>M</td><td>57</td><td>T3N0</td><td>Oropharynx</td><td>CDDP</td><td>46.5</td><td>23.8</td><td>31.2</td><td>32.1</td><td>31.2</td><td>29.3</td><td>31.3</td></tr><tr><td>17</td><td>M</td><td>64</td><td>T3N2c</td><td>Epiglottic</td><td>CDDP</td><td>109.8</td><td>23.5</td><td>15.6</td><td>39.6</td><td>17.3</td><td>49.3</td><td>7.8</td></tr><tr><td>18</td><td>M</td><td>55</td><td>T1N2b</td><td>Tonsil</td><td>CDDP</td><td>31</td><td>20.2</td><td>20.8</td><td>25.7</td><td>23.63</td><td>18.7</td><td>15.3</td></tr><tr><td>19</td><td>M</td><td>65</td><td>T4N0</td><td>Velum</td><td>CDDP</td><td>10.1</td><td>23.7</td><td>25.3</td><td>28.6</td><td>28.2</td><td>24</td><td>23.2</td></tr><tr><td>20</td><td>M</td><td>56</td><td>T4N2b</td><td>Pharyngeal wall</td><td>CDDP</td><td>150</td><td>32.4</td><td>26.8</td><td>45</td><td>24.4</td><td>62.8</td><td>16.6</td></tr></table> |
1afb1d0799ac6996d4cb7eed0fd6b25cba1d2d6fc25853dd4eafeb0a9ed8d327.png | complex | <table><tr><td rowspan="2"></td><td></td><td colspan="3">Recalling and understanding (part A)</td><td colspan="3">Applying (part B)</td><td colspan="3">Total (part A & B)</td></tr><tr><td><i>N</i></td><td><i>M</i></td><td><i>SD</i></td><td>Min–max</td><td><i>M</i></td><td><i>SD</i></td><td>Min–max</td><td><i>M</i></td><td><i>SD</i></td><td>Min–max</td></tr><tr><td>Pre-test</td><td>7</td><td>3.07</td><td>1.26</td><td>1–5</td><td>0.86</td><td>0.69</td><td>0–2</td><td>3.93</td><td>1.16</td><td>3–6</td></tr><tr><td>Post-test</td><td>7</td><td>5.07</td><td>1.15</td><td>4–7</td><td>1.57</td><td>0.98</td><td>0–3</td><td>6.64</td><td>1.27</td><td>5–9</td></tr><tr><td>Follow-up</td><td>7</td><td>5.14</td><td>1.56</td><td>4–8</td><td>1.29</td><td>0.95</td><td>0–3</td><td>6.43</td><td>2.16</td><td>5–11</td></tr></table> |
f25b87020e4f7779e57fdf42728dbeeac6af48d874ab87c51749147e9e1adeb1.png | simple | <table><tr><td>Farm</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>nr. of samples</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td><td>10</td></tr><tr><td>nr. of PRM/sample</td><td>50</td><td>50-100</td><td>100</td><td>50</td><td>50</td><td>50</td><td>50-100</td><td>50-100</td></tr><tr><td>layers on the farm</td><td>No</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td></tr><tr><td>nr. of layers on the farm</td><td>0*</td><td>6,000</td><td>12,000</td><td>15,000</td><td>20,000</td><td>18,000</td><td>16,000</td><td>0</td></tr><tr><td>Salmonella PCR</td><td>+</td><td>+</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>+</td></tr></table> |
77c03afb3b610d87ed502d0f82baf5c7e5cb82af3fdef4d840b46dec3231b2c9.png | simple | <table><tr><td></td><td>Percentage agree or strongly agree (n = 37)</td></tr><tr><td>Knowledge translation was hampered by a lack of incentives for KTE activities within organisations that conduct health systems and policy research (HSPR)</td><td>38</td></tr><tr><td>Organisations that conduct HSPR made available financial and human resources to assist with KTE activities</td><td>24</td></tr><tr><td>Organisations that conduct HSPR were not seen as a credible source of research</td><td>14</td></tr></table> |
4051725750cb3b7738db0d2f42ffaa13fc8b05390079c9a802cbcbaf02cf5491.png | complex | <table><tr><td></td><td colspan="2">2012 (<i>N = 18,558</i>)</td><td colspan="2">2006 (<i>N = 12,443</i>)</td><td colspan="2">2000 (<i>N = 9,049</i>)</td><td colspan="2">1994 (<i>N = 8,864</i>)</td></tr><tr><td>Age group</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td><td>Male (%)</td><td>Female (%)</td></tr><tr><td><30</td><td>13.59</td><td>15.31</td><td>15.48</td><td>16.71</td><td>15.05</td><td>16.99</td><td>13.47</td><td>14.68</td></tr><tr><td>31–44</td><td>11.26</td><td>13.46</td><td>10.70</td><td>12.43</td><td>11.40</td><td>13.08</td><td>13.19</td><td>14.77</td></tr><tr><td>45–60</td><td>10.56</td><td>14.65</td><td>10.70</td><td>14.66</td><td>9.15</td><td>12.06</td><td>10.1</td><td>12.92</td></tr><tr><td>61–74</td><td>4.89</td><td>9.45</td><td>4.40</td><td>8.71</td><td>6.27</td><td>10.86</td><td>6.0</td><td>9.7</td></tr><tr><td>≥75</td><td>1.79</td><td>5.05</td><td>1.49</td><td>4.71</td><td>1.12</td><td>4.02</td><td>1.12</td><td>4.06</td></tr><tr><td>Total (%)</td><td>42.08</td><td>57.92</td><td>42.78</td><td>57.22</td><td>42.99</td><td>57.01</td><td>43.87</td><td>56.13</td></tr><tr><td>Household size (mean)</td><td colspan="2">4.26**</td><td colspan="2">4.35^</td><td colspan="2">4.04^^</td><td colspan="2">3.41*</td></tr><tr><td>Working status (employed %)</td><td colspan="2">56.16</td><td colspan="2">54.25</td><td colspan="2">49.52</td><td colspan="2">54.66</td></tr><tr><td>Adult equivalent household mean income (roubles) per month<sup>a</sup></td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td> Male (head)</td><td colspan="2">7,690.00</td><td colspan="2">5,290.00</td><td colspan="2">2,730.00</td><td colspan="2">4,280.00</td></tr><tr><td> Female (head)</td><td colspan="2">7,360.00</td><td colspan="2">4,990.00</td><td colspan="2">2,510.00</td><td colspan="2">4,080.00</td></tr><tr><td>Asset-holding (%)</td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td> All durable assets<sup>b</sup> but no car or tractor</td><td colspan="2">88.23</td><td colspan="2">65.19</td><td colspan="2">77.74</td><td colspan="2">68.19</td></tr><tr><td> All durable assets with car and/or tractor</td><td colspan="2">11.42</td><td colspan="2">30.92</td><td colspan="2">19.31</td><td colspan="2">29.28</td></tr><tr><td> Positive wealth group<sup>c</sup> (%)</td><td colspan="2">89.87</td><td colspan="2">86.64</td><td colspan="2">90.71</td><td colspan="2">92.73</td></tr><tr><td> Living standard (access to all publiclyprovided services) %</td><td colspan="2">95.25</td><td colspan="2">91.69</td><td colspan="2">86.81</td><td colspan="2">83.36</td></tr><tr><td>Geography of residence (%)</td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td> Urban</td><td colspan="2">68.06</td><td colspan="2">68.79</td><td colspan="2">65.12</td><td colspan="2">70.23</td></tr><tr><td> Rural</td><td colspan="2">31.94</td><td colspan="2">31.21</td><td colspan="2">34.88</td><td colspan="2">29.77</td></tr></table> |
c9c4b3275e6736b47685a6c0e45f62c619624d815c76ff6063f9ba07e6f0da06.png | complex | <table><tr><td colspan="2"> </td><td> </td><td>ID code</td><td>Sex</td><td>Age (Years)</td><td>Time in facility (Years)</td><td>Staff position</td></tr><tr><td colspan="3">Dyads</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Resident</td><td>R1</td><td>F</td><td>84</td><td>6</td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F1</td><td>F</td><td>55</td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 2</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Resident</td><td>R2</td><td>F</td><td>79</td><td>1.5</td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F2</td><td>F</td><td>56</td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 3</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Resident</td><td>R3</td><td>M</td><td>89</td><td>1</td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F3</td><td>F</td><td>43</td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 4</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Resident</td><td>R4</td><td>F</td><td>84</td><td>2</td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F4</td><td>M</td><td>53</td><td> </td><td> </td></tr><tr><td> </td><td colspan="2">Dyad 5</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Resident</td><td>R5</td><td>F</td><td>89</td><td>3</td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F5(a)</td><td>F</td><td>57</td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Family</td><td>F5(b)</td><td>M</td><td>62</td><td> </td><td> </td></tr><tr><td colspan="2">Staff</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="2"> </td><td>Staff 1</td><td>S1</td><td>F</td><td>54</td><td> </td><td>Lifestyle manager</td></tr><tr><td colspan="2"> </td><td>Staff 2</td><td>S2</td><td>F</td><td>41</td><td> </td><td>Personal Care Worker</td></tr><tr><td colspan="2"> </td><td>Staff 3</td><td>S3</td><td>F</td><td>50</td><td> </td><td>Care Manager</td></tr><tr><td colspan="2"> </td><td>Staff 4</td><td>S4</td><td>F</td><td>-</td><td> </td><td>Personal Care Worker</td></tr><tr><td colspan="2"> </td><td>Staff 5</td><td>S5</td><td>F</td><td>60</td><td> </td><td>Enrolled Nurse</td></tr><tr><td colspan="2"> </td><td>Staff 6</td><td>S6</td><td>F</td><td>52</td><td> </td><td>Diversional Therapist</td></tr><tr><td colspan="2"> </td><td>Staff 7</td><td>S7</td><td>F</td><td>30</td><td> </td><td>Endorsed Enrolled Nurse</td></tr></table> |
5969ca2d8d96b9806326c49a2017f9d6b864ee68dafea1766506d0744b1f7187.png | simple | <table><tr><td>Mitochondrial abnormality</td><td>MS</td><td>CFS</td><td>PD</td><td>AUT</td><td>MDD</td><td>Schiz</td><td>BPD</td></tr><tr><td>Ultrastructural abnormalities in mitochondria</td><td>+</td><td>++</td><td>+</td><td>+</td><td>+</td><td>+++</td><td>+</td></tr><tr><td>Evidence to shift in energy production via glycolysis</td><td>+</td><td>++</td><td>++</td><td>++</td><td></td><td>++</td><td>++</td></tr><tr><td>Mitochondrial dysfunction in peripheral immune cells</td><td>+</td><td>++</td><td>++</td><td>++</td><td>++</td><td>++</td><td>+</td></tr><tr><td>Mitochondria DNA damage</td><td>+</td><td></td><td></td><td></td><td></td><td>++</td><td></td></tr><tr><td>Damage to the electron transport chain</td><td>++</td><td></td><td>+++</td><td>+</td><td></td><td>++</td><td>+</td></tr><tr><td>High lactate in brain or cerebrospinal fluid</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>++</td><td>+</td></tr><tr><td>Bioenergetic impairment Skeletal muscle</td><td></td><td>+++</td><td></td><td></td><td>+</td><td></td><td></td></tr><tr><td>Decreased mitochondrial membrane potential</td><td></td><td>+</td><td>+</td><td></td><td></td><td></td><td></td></tr></table> |
c68fbc847851e594e55be12c5212f51ce67a296a904614e788e8a86f2a6d2ca3.png | simple | <table><tr><td> </td><td>T1</td><td>T2</td><td>T3</td><td>T4</td><td>T5</td></tr><tr><td>Case 1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> SNA</td><td>82.7</td><td>82.6</td><td>81.3</td><td>81.7</td><td>81.8</td></tr><tr><td> SNB</td><td>68.0</td><td>68.7</td><td>70.1</td><td>70.2</td><td>71.4</td></tr><tr><td> ANB</td><td>14.7</td><td>13.8</td><td>11.3</td><td>11.5</td><td>10.4</td></tr><tr><td> SN-Pog</td><td>65.8</td><td>70.1</td><td>69.1</td><td>69.1</td><td>70.6</td></tr><tr><td> SN-Mp</td><td>60.2</td><td>51.1</td><td>52.3</td><td>52.1</td><td>54.0</td></tr><tr><td> SN-Occ</td><td>26.3</td><td>27.1</td><td>27.3</td><td>27.8</td><td>32.3</td></tr><tr><td> Interincisal</td><td>115.6</td><td>115.5</td><td>123.1</td><td>126.3</td><td>129.6</td></tr><tr><td> L1-Mp</td><td>89.0</td><td>97.5</td><td>92.9</td><td>90.8</td><td>91.2</td></tr><tr><td>Case 2</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> SNA</td><td>74.7</td><td>74.2</td><td>74.5</td><td>74.1</td><td>73.7</td></tr><tr><td> SNB</td><td>63.9</td><td>62.6</td><td>66.4</td><td>67.6</td><td>70.3</td></tr><tr><td> ANB</td><td>10.9</td><td>11.6</td><td>8.1</td><td>6.5</td><td>3.3</td></tr><tr><td> SN-Pog</td><td>64.4</td><td>66.6</td><td>66.8</td><td>67.7</td><td>71.0</td></tr><tr><td> SN-Mp</td><td>53.4</td><td>52.1</td><td>51.0</td><td>49.0</td><td>49.1</td></tr><tr><td> SN-Occ</td><td>19.6</td><td>29.0</td><td>29.3</td><td>24.4</td><td>23.5</td></tr><tr><td> Interincisal</td><td>99.9</td><td>122.3</td><td>120.4</td><td>105.3</td><td>117.3</td></tr><tr><td> L1-Mp</td><td>95.8</td><td>101.0</td><td>100.4</td><td>95.7</td><td>93.2</td></tr><tr><td>Case 3</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> SNA</td><td>86.7</td><td>86.1</td><td>86.3</td><td>86.2</td><td>86.0</td></tr><tr><td> SNB</td><td>72.0</td><td>70.0</td><td>74.7</td><td>73.8</td><td>77.2</td></tr><tr><td> ANB</td><td>14.7</td><td>16.1</td><td>11.6</td><td>12.4</td><td>8.8</td></tr><tr><td> SN-Pog</td><td>69.4</td><td>72.5</td><td>73.2</td><td>72.6</td><td>76.4</td></tr><tr><td> SN-Mp</td><td>54.5</td><td>52.4</td><td>50.1</td><td>52.0</td><td>48.6</td></tr><tr><td> SN-Occ</td><td>18.4</td><td>24.3</td><td>23.5</td><td>24.0</td><td>25.3</td></tr><tr><td> Interincisal</td><td>106.2</td><td>113.5</td><td>115.2</td><td>117.4</td><td>115.4</td></tr><tr><td> L1-Mp</td><td>95.0</td><td>97.3</td><td>93.0</td><td>91.4</td><td>96.4</td></tr></table> |
cb0ea8b5f810bfdc9b3ecec756b38b6408cab38ed854fcb3b292daed56fd43e4.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Age/Gender</td><td rowspan="2">Experience in Using EPW</td><td colspan="2">Type of Disabilities</td></tr><tr><td>Motor</td><td>Cognition</td></tr><tr><td>User I</td><td>60-year-old male</td><td>Yes</td><td>Lower body amputation by diabetes</td><td>Low cognition/reflexes by dementia</td></tr><tr><td>User II</td><td>48-year-old female</td><td>Yes</td><td>Amyotrophic lateral sclerosis</td><td>-</td></tr><tr><td>User III</td><td>32-year-old female</td><td>Yes</td><td>Cerebral palsy</td><td>-</td></tr><tr><td>User IV</td><td>73-year-old male</td><td>Yes</td><td>Lack of strength</td><td>Weak senile dementia</td></tr><tr><td>User V</td><td>28-year-old female</td><td>Yes</td><td>Spinal cord injury</td><td>-</td></tr></table> |
095883369f809bbf0f5e6d41acfe93371ad219dd7b01e1a755a8c5b1a7fc229b.png | simple | <table><tr><td>Group</td><td>EPG</td><td>Egg reduction rate (%)</td></tr><tr><td>PBS (<i>n</i> = 5)</td><td>76.60 ± 7.427</td><td>–</td></tr><tr><td><i>B.s</i>-CotC (n <i>=</i> 5)</td><td>74.80 ± 8.194</td><td>–</td></tr><tr><td>Oral (n <i>=</i> 5)<sup>a</sup></td><td>39.60 ± 3.945<sup>**</sup></td><td>48.30</td></tr><tr><td>Injected (<i>n</i> = 5)<sup>b</sup></td><td>37.40 ± 3.647<sup>**</sup></td><td>51.20</td></tr></table> |
1b049c1c3c77b93523c1ccf2087df32eb3c4cf55d43a41436ac6a7be64102d70.png | complex | <table><tr><td rowspan="2"> Diagnosis</td><td>12 to 14 years old</td><td>15 to 17 years old</td></tr><tr><td>(<i>n</i> = 9)</td><td>(<i>n</i> = 7)</td></tr><tr><td>ADHD</td><td>3</td><td>1</td></tr><tr><td>ODD</td><td></td><td>2</td></tr><tr><td>MDD</td><td></td><td>2</td></tr><tr><td>PTSD</td><td>1</td><td></td></tr><tr><td>Social phobia</td><td>1</td><td></td></tr><tr><td>ADHD/DBD</td><td>2</td><td></td></tr><tr><td>ADHD/ODD</td><td>1</td><td></td></tr><tr><td>ADHD/MDD</td><td></td><td>2</td></tr><tr><td>ADHD/PTSD/ODD</td><td>1</td><td></td></tr></table> |
dedd8ed8872c1013c172db3e68cd3b72b9df9b763efb9bd505a342dc49f71ec2.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Classification of chronic malnutrition</td><td rowspan="2">Test statistic</td></tr><tr><td>Normal % [95 % confidence interval]</td><td>Stunted % [95 % confidence interval]</td></tr><tr><td>Religion of mother</td><td></td><td></td><td></td></tr><tr><td> Christianity</td><td>81.8 [CI: 78.7 – 84.6]</td><td>18.2 [CI: 15.4 – 21.3]</td><td rowspan="3">χ<sup>2</sup> = 9.4 <i>p</i> = 0.038</td></tr><tr><td> Islam</td><td>76.2 [CI: 72.3 – 79.7]</td><td>23.8 [CI: 20.3 – 27.7]</td></tr><tr><td> ATR</td><td>75.4 [CI: 68.5 – 81.2]</td><td>24.6 [CI: 18.8 – 31.5]</td></tr><tr><td>Age of child (months)</td><td></td><td></td><td></td></tr><tr><td> 6-8</td><td>90.6 [CI: 86.2– 93.7]</td><td>9.4 [CI: 6.3 – 13.8]</td><td rowspan="2">χ<sup>2</sup> = 31.0 <i>p</i> <0.001</td></tr><tr><td> 9-23</td><td>76.3 [CI: 73.6– 78.7]</td><td>23.7 [CI: 21.3 – 26.4]</td></tr><tr><td>Gender of child</td><td></td><td></td><td></td></tr><tr><td> Male</td><td>75.5 [CI: 72.4 – 78.3]</td><td>24.5 [CI: 21.7 – 27.6]</td><td rowspan="2"><i>χ</i><sup><i>2</i></sup> = 11.5 , <i>p</i> = 0.001</td></tr><tr><td> Female</td><td>81.7 [CI: 78.6 – 84.5]</td><td>18.3 [CI: 15.5 – 21.4]</td></tr><tr><td rowspan="2">Characteristic</td><td colspan="2">Classification of chronic malnutrition</td><td rowspan="2">Test statistic</td></tr><tr><td>Normal</td><td>Stunted</td></tr><tr><td>Household wealth index</td><td></td><td></td><td></td></tr><tr><td> Low</td><td>77.9 [CI: 75.4 – 80.2]</td><td>22.1 [CI: 19.8 – 24.6]</td><td rowspan="2"><i>χ</i><sup><i>2</i></sup> = 5.5 , <i>p</i> = 0.01</td></tr><tr><td> High</td><td>87.5 [CI: 80.2 – 92.4]</td><td>12.5 [CI: 7.6 – 19.8]</td></tr><tr><td>Salt Iodine Content</td><td></td><td></td><td rowspan="3"><i>χ</i><sup><i>2</i></sup> = 8.7 , <i>p</i> = 0.03</td></tr><tr><td> 0 ppm</td><td>76.6 [CI: 73.4 – 79.6]</td><td>23.4 [CI: 20.4 – 26.6]</td></tr><tr><td> Less than 15 ppm</td><td>78.0 [CI: 74.2 – 81.4]</td><td>22.0 [CI: 18.6 – 25.8]</td></tr><tr><td> ≥15 ppm</td><td>84.6 [CI: 79.3 – 88.7]</td><td>15.4 [CI: 11.3 – 20.7]</td><td></td></tr><tr><td>CWC Attendance</td><td></td><td></td><td></td></tr><tr><td> 1-2</td><td>76.3 [CI: 72.1 – 80.0]</td><td>23.7 [CI: 20.0 – 27.9]</td><td rowspan="3">χ<sup>2</sup> = 6.7 , p = 0.03</td></tr><tr><td> 3-4</td><td>80.6 [CI: 77.5 – 83.4]</td><td>19.4 [CI: 16.6 – 22.5]</td></tr><tr><td> 4+</td><td>94.7[CI: 80.8 – 98.7]</td><td>5.3[CI: 1.3 – 19.2]</td></tr><tr><td>Maternal Educational level</td><td></td><td></td><td></td></tr><tr><td> None</td><td>77.2 [CI: 74.4 – 79.8]</td><td>22.8 [CI: 20.2 – 25.6]</td><td rowspan="3">χ<sup>2</sup> = 5.6 , <i>p</i> = 0.04</td></tr><tr><td> Low</td><td>81.2 [CI: 77.1 – 84.7]</td><td>18.8 [CI: 15.3 – 22.9]</td></tr><tr><td> High</td><td>85.3 [CI: 77.5 – 90.7]</td><td>14.7 [CI: 9.3 – 22.5]</td></tr><tr><td>ANC Attendance</td><td></td><td></td><td></td></tr><tr><td> <4 times</td><td>72.2 [CI: 66.9 – 76.9]</td><td>27.8 [CI: 23.1 – 33.1]</td><td rowspan="2">χ<sup>2</sup> = 12.3 , <i>p</i> = 0.003</td></tr><tr><td> ≥4 times</td><td>80.3 [CI: 77.4 – 82.8]</td><td>19.7 [CI: 17.2 – 22.6]</td></tr><tr><td>Timing of first complementary food at 6 months</td><td></td><td></td><td></td></tr><tr><td> No</td><td>748 (77.0)</td><td>224 (23.0)</td><td rowspan="2">χ<sup>2</sup> = 5.4 , <i>p</i> = 0.02</td></tr><tr><td> Yes</td><td>752 (81.3)</td><td>173 (18.7)</td></tr></table> |
7c61a2564a3084f8406f37b4dcabf4054a982c390341602f16765ebc200761de.png | simple | <table><tr><td>Genus/subgenus</td><td>Species</td><td>No. of unique conotoxin precursors</td><td>No. of unique mature toxins</td><td>No. of gene superfamilies</td><td>No. of cysteine frameworks</td><td>Most abundant gene superfamily and frequency<sup>a</sup></td><td>Main diet summarized from [29, 42]</td></tr><tr><td><i>Puncticulis</i></td><td><i>arenatus</i></td><td>326</td><td>256</td><td>36</td><td>31</td><td>O1, (20.3 %)</td><td>eunicids, nereids, capitellids</td></tr><tr><td><i>Californiconus</i></td><td><i>californicus</i></td><td>185</td><td>164</td><td>30</td><td>21</td><td>O1, (20.1 %)</td><td>molluscs, polychaetes, fish</td></tr><tr><td><i>Virroconus</i></td><td><i>coronatus</i></td><td>331</td><td>286</td><td>32</td><td>30</td><td>O1, (19.6 %)</td><td>eunicids, capitellids</td></tr><tr><td><i>Virroconus</i></td><td><i>ebraeus</i></td><td>75</td><td>69</td><td>27</td><td>23</td><td>M, (31.9 %)</td><td>eunicids, nereids</td></tr><tr><td><i>Stephanoconus</i></td><td><i>imperialis</i></td><td>70</td><td>66</td><td>20</td><td>19</td><td>P, (16.7 %)</td><td>amphinomids</td></tr><tr><td><i>Lividoconus</i></td><td><i>lividus</i></td><td>244</td><td>204</td><td>31</td><td>25</td><td>O1, (10.7 %)</td><td>enteropneusts, terebellids</td></tr><tr><td><i>Conus</i></td><td><i>marmoreus</i></td><td>81</td><td>69</td><td>14</td><td>16</td><td>M, (26.1 %)</td><td>gastropods</td></tr><tr><td><i>Lividoconus</i></td><td><i>quercinus</i></td><td>97</td><td>78</td><td>25</td><td>23</td><td>O1, (15.4 %)</td><td>enteropneusts, sabellids</td></tr><tr><td><i>Rhizoconus</i></td><td><i>rattus</i></td><td>102</td><td>89</td><td>28</td><td>30</td><td>con-ikot-ikot, (18 %)</td><td>eunicids</td></tr><tr><td><i>Harmoniconus</i></td><td><i>sponsalis</i></td><td>401</td><td>338</td><td>35</td><td>29</td><td>O1, (28.1 %)</td><td>eunicids, nereids</td></tr><tr><td><i>Strategoconus</i></td><td><i>varius</i></td><td>198</td><td>168</td><td>29</td><td>24</td><td>M, (10.7 %)</td><td>polychaetes</td></tr><tr><td><i>Virgiconus</i></td><td><i>Virgo</i></td><td>113</td><td>78</td><td>25</td><td>21</td><td>O1, (24.4 %)</td><td>terebellids</td></tr></table> |
1d106221768068eadd6f37589bf5f8e35c6ddf27f9818e083dd333f92d8bc44a.png | complex | <table><tr><td></td><td colspan="4">Customers-Suppliers vignettes</td><td colspan="4">Employees-Suppliers vignettes</td><td colspan="4">Employees-Environment vignettes</td></tr><tr><td></td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td><td>Effect</td><td>SE</td><td>LL95%CI</td><td>UL95%CI</td></tr><tr><td>−1SD</td><td>0.20</td><td>0.09</td><td>0.06</td><td>0.40</td><td>0.27</td><td>0.18</td><td>−0.07</td><td>0.63</td><td>−0.21</td><td>0.100</td><td>−0.46</td><td>−0.06</td></tr><tr><td>Mean</td><td>0.37</td><td>0.08</td><td>0.22</td><td>0.55</td><td>0.46</td><td>0.10</td><td>0.27</td><td>0.68</td><td>−0.15</td><td>0.07</td><td>−0.32</td><td>−0.04</td></tr><tr><td>+1SD</td><td>0.59</td><td>0.14</td><td>0.36</td><td>0.91</td><td>0.59</td><td>0.17</td><td>0.30</td><td>0.99</td><td>−0.05</td><td>0.10</td><td>−0.29</td><td>0.14</td></tr></table> |
7ec163a5de7a11912cb13dc5f8444c32827c50555ad74877249dfe221f0edc21.png | simple | <table><tr><td>Symptoms</td><td>EG</td><td>YG</td><td><i>P</i></td></tr><tr><td>Heartburn</td><td>1.6 ± 0.89</td><td>2.8 ± 0.76</td><td><0.05</td></tr><tr><td>Acid regurgitation</td><td>1.6 ± 0.98</td><td>2.4 ± 0.91</td><td><0.05</td></tr><tr><td>Solid food dysphagia</td><td>1.7 ± 0.78</td><td>0.6 ± 0.22</td><td><0.05</td></tr><tr><td>Chest pain</td><td>1.7 ± 0.84</td><td>1.5 ± 0.89</td><td>>0.05</td></tr><tr><td>Respiratory complication</td><td>1.9 ± 1.06</td><td>1.1 ± 0.47</td><td><0.05</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.